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ABSTRACT 
 
JONATHAN TABB SULLIVAN: The Role of the Mycobacterium tuberculosis SecA2 
Protein Export Pathway in Virulence 
(Under the direction of Miriam Braunstein) 
 
 Mycobacterium tuberculosis is an intracellular bacterial pathogen that replicates 
in macrophages in the lung of the host. The ability to replicate in these cells of the 
immune system is critical to the virulence of this important pathogen. M. tuberculosis is 
thought to maintain a hospitable niche in the host through several mechanisms.  M. 
tuberculosis suppresses the host innate immune response by dampening cytokine 
secretion and production of reactive nitrogen and oxygen species that can be toxic to 
bacteria.  Additionally, M. tuberculosis manipulates macrophages by arresting the normal 
process of phagosome maturation into acidified and hydrolytic phagolysosomes.  The 
process of each of these immunosuppressive functions by M. tuberculosis is not fully 
understood. Other intracellular pathogens that control the host immune response use 
specialized protein export systems to deliver effectors to the host cell.  In M. tuberculosis, 
the accessory SecA2 system is a specialized protein export system that is required for 
intracellular growth in macrophages.  However, we do not understand the role of SecA2 
in promoting growth in macrophages. The SecA2 system has a role in dampening the 
host cytokine and reactive nitrogen response. However, we show that the role of SecA2 
in dampening these inflammatory responses cannot explain the intracellular growth 
defect. In this study we discovered that SecA2 is also required for blocking phagosome 
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maturation. We showed that inhibitors of phagosome acidification rescued the 
intracellular growth defect of the ΔsecA2 mutant, which demonstrated that the 
phagosome maturation arrest defect of the ΔsecA2 mutant is responsible for the 
intracellular growth defect.  Our data suggests there are effectors of phagosome 
maturation that are exported into the host environment by the accessory SecA2 system.  
Thus, we tested a set of putative effectors of M. tuberculosis phagosome maturation for 
SecA2 dependent export. We found that the level of one of these proteins, the secreted 
acid phosphatase (SapM), was reduced in the ∆secA2 mutant. The research presented in 
this thesis establishes a role for SecA2 in promoting M. tuberculosis growth in 
macrophages. Additionally, we demonstrate an important causal link between phagosome 
maturation and arrest of M. tuberculosis intracellular replication. 
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CHAPTER I 
 
 
INTRODUCTION  
 
 
 Robert Koch described Mycobacterium tuberculosis as the bacterium that causes 
tuberculosis (TB) in 1882. Despite having been known as the causative agent of TB for 
over 100 years, M. tuberculosis currently infects approximately one-third of the world’s 
population and TB is estimated to kill nearly two million people each year (107). Neither 
universally effective vaccines (33), nor fast-acting sterilizing drugs exist to treat TB. 
Additionally, M. tuberculosis is quickly evolving resistance mechanisms to the current 
drugs in use to treat infection. Taken together these factors create a need for new drugs 
and vaccines to combat TB. Research into the virulence mechanisms of M. tuberculosis 
will facilitate efforts to identify novel drug targets and vaccine strategies.   
 
1.1- Challenges and limitations of current TB drugs and vaccines 
M. tuberculosis has a variety of intrinsic drug resistance characteristics that make 
it difficult to treat with our current array of antibiotics. Antibiotics that have a 
cytoplasmic target in M. tuberculosis are impeded by a very hydrophobic cell envelope 
that limits drug entry, and the existence of efflux pumps that can keep cytoplasmic drug 
levels low by pumping drugs out of the cytoplasm (25, 43). β-lactam antibiotics that 
target extracellular enzymes are also inefficient due to the M. tuberculosis β-lactamase 
BlaC (47). Further, because the current TB drugs work on replicating bacteria, the drugs 
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in use are hindered by the unusually slow replication rate of M. tuberculosis, which 
necessitates long treatment times. 
In addition to the inherent drug resistance capabilities of M. tuberculosis, this 
bacterial pathogen is quickly evolving resistance mechanisms to the current drugs used to 
treat TB infection. Strains that have developed drug resistance to current TB therapies are 
termed Multi Drug Resistant (MDR) or Extensively Drug Resistant (XDR) TB. The 
World Health Organization defines MDR strains as strains that are resistant to both of the 
first-line drugs rifampin and isoniazid. XDR strains are defined as having MDR 
resistance plus resistance to at least two second-line drugs.  
An effective vaccine would supplant the need for drugs to treat M. tuberculosis. 
Currently, there is a live attenuated vaccine strain for TB, M. bovis Bacille Calmette-
Guerin (BCG), that is used in most of the world. The BCG vaccine was introduced in the 
1920’s, but subsequent studies have shown huge discrepancies in the vaccine’s efficacy, 
from as high as 80% protection against TB in England to 0% protection in a study 
conducted in India (33). Due to its questionable efficacy and the complications it presents 
to the diagnostic TB skin test, the BCG vaccine is not used in the United States. The 
current status of drugs and vaccines against TB are insufficient to deal with the emerging 
drug-resistant strains. Studies of the virulence of M. tuberculosis could lead to new drug 
and vaccine strategies capable of reducing the impact of drug-resistant TB. 
 
1.2- Route of M. tuberculosis infection 
The development of new drugs and vaccines for TB is particularly important because TB 
is a serious disease that causes substantial human mortality and is easily spread among 
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the human population. M. tuberculosis resides in the lungs of infected individuals. A 
person with active TB disease can aerosolize infectious bacteria by coughing, sneezing or 
even talking. When an uninfected individual inhales M. tuberculosis, the bacteria travel 
to the bronchioles and alveolar sacs within the lungs. In these spaces  M. tuberculosis is 
phagocytosed by resident alveolar macrophages and contained within the macrophage in 
a membrane bound compartment called a phagosome (34). Macrophages generally 
destroy bacteria through the phagocytic pathway by creating a hydrolytic, antimicrobial, 
and degradative environment within the phagosome.  The formation of this degradative 
phagosomal compartment is a multi-step process termed phagosome maturation (34). M. 
tuberculosis has the amazing ability to survive and even replicate after its uptake by 
macrophages. Once in macrophages, M. tuberculosis prevents phagosome maturation 
from occurring normally, which results in M. tuberculosis residing in a more hospitable 
phagosomal compartment. This early phase of bacterial replication in host phagosomes is 
referred to as primary infection. 
It is generally believed that the ability of M. tuberculosis to survive and replicate 
during primary infection depends on the pathogen blocking the normal process of 
phagosome maturation of macrophages (4, 82, 102). There are, however, additional 
effects of M. tuberculosis on the host that could be critical to the success of this pathogen 
during primary infection. Apoptotic cell death can control replication of intracellular M. 
tuberculosis (67, 73). M. tuberculosis is able to reduce apoptotic cell death in favor of 
necrotic cell death, which promotes cell-to-cell spread of the bacteria (67). M. 
tuberculosis also dampens the inflammatory response by repressing macrophage 
production of cytokines. This dampening of the cytokine response affects recruitment of 
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immune cells that could help clear infection, potentially contributing to the ability of M. 
tuberculosis to replicate during primary infection. Because some of the cytokines whose 
levels are dampened by M. tuberculosis are able to activate macrophages to control 
bacillary growth, this modulation of the immune response could also be important for 
facilitating intracellular replication of the bacterium.  
Eventually during infection, an immunocompetent host will develop a TH1-
skewed adaptive immune response to M. tuberculosis. When the TH1 response is fully 
developed the growth of the bacteria is arrested and the next phase of TB infection 
begins. Growth is arrested by an influx of antigen specific T-cells that produce gamma 
interferon (IFN-γ), which activates the infected macrophages to a point where they can 
arrest M. tuberculosis replication (36). Notably, M. tuberculosis can persist in this state; 
this phase of infection is called latency.  During latency M. tuberculosis replicates very 
slowly and maintains homeostasis (44). M. tuberculosis can emerge from latency through 
reactivation if the host immune system is adversely affected such that the adaptive 
response is dampened. Some of the more common causes of immune repression that lead 
to reactivation of TB disease are HIV, immunosuppressive treatments, or aging. 
Reactivation of a latent M. tuberculosis infection leads to active bacterial 
replication, wasting disease and eventually death of the infected person. This phase of 
infection is called secondary infection.  
The research in this thesis is directed at understanding the primary phase of M. 
tuberculosis infection, with the goal of helping to understand the virulence mechanisms 
of M. tuberculosis that enable replication in macrophages. In particular we studied the 
SecA2 protein export pathway, which was shown previously to be required for growth in 
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macrophages (60).  We set out to understand the role of SecA2 in virulence as a way to 
learn more about TB pathogenesis during this important phase of infection.  
Other intracellular bacterial pathogens that carve out a niche within macrophage 
phagosomes, such as Salmonella and Legionella, use specialized secretion systems to 
deliver effectors to the host cell (42, 50). Some of the effectors they deliver are involved 
in trafficking and control of the environment within the phagosome. M. tuberculosis is 
known to have two types of specialized secretion systems: ESX systems and the SecA2 
system. One of the five ESX systems, the ESX-1 system, has been shown to have 
functions in promoting growth in macrophages and in the process of phagosome 
maturation arrest. The SecA2 system is also known to promote growth in macrophages 
(12, 60). Here, we further characterize the role of the SecA2 system in virulence, and find 
that it also has a role in phagosome maturation arrest. It has long been thought that the 
ability to block phagosome maturation is a keystone to M. tuberculosis pathogenesis (4). 
However, it has not been firmly established that a failure to block phagosome maturation 
prevents M. tuberculosis growth.  Through the course of studying the role of the SecA2 
system in promoting growth of M. tuberculosis in macrophages, we demonstrate in this 
thesis that phagosome maturation arrest is necessary for intracellular M. tuberculosis 
replication and that the failure to properly block phagosome maturation can inhibit M. 
tuberculosis growth. 
 
1.3- Macrophages as a host defense against infection 
 As an intracellular pathogen, M. tuberculosis requires a host cell to grow in vivo. 
Upon inhalation, the first productive contact between M. tuberculosis and the host is 
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alveolar macrophages. In the lung, alveolar macrophages that reside in the bronchioles 
and alveolar sacs are the first line of defense of the immune system. Alveolar 
macrophages have the important job of detecting, consuming, degrading, and presenting 
antigens of bacteria and fungi to the immune system (31). Macrophages also have the 
capacity to clear apoptotic cells and inert particles. 
 Resident alveolar macrophages readily destroy foreign organisms such as 
bacteria; they do this through the process of phagocytosis and phagosome maturation (34, 
58). Phagocytosis is the term used to describe host cell engulfment of particles greater 
than 0.5µm in size.  Once phagocytosed, a foreign body resides in a membrane-encased 
compartment called a phagosome.  Phagosome maturation is the subsequent process 
through which the phagosome is converted to an acidic, hydrolytic compartment in order 
to degrade the contents of the phagosomal lumen. The process of phagosome maturation 
is driven by sequential fusion events with endosomes and lysosomes that deliver 
hydrolytic enzymes and the vacuolar H+-ATPase (V-ATPase), which drives acidification 
of the phagosome (35). 
 When containment or destruction via phagocytosis and phagosome maturation 
fails, macrophages can undergo apoptosis to prevent spread of intracellular bacteria. By 
containing the bacteria in an apoptotic body the macrophage can recruit other phagocytes, 
and induce phagocytosis and destruction of the apoptotic corpse. Because the bacteria are 
now contained in an apoptotic body the potential for them to interact with and affect the 
recruited phagocyte is diminished compared to direct phagocytosis of the bacteria.  
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1.4- Macrophage phagocytosis  
Phagocytosis can lead to varied outcomes that depend on mode of entry and cargo 
of the initial phagosome (34). Phagocytosis begins with recognition of the particle to be 
consumed. This recognition is performed by surface receptors on the phagocyte (Figure 
1-1). In addition to the receptors that are required for phagocytosis of bacteria, e.g. 
complement receptors, Fcγ receptor, mannose receptor, and scavenger receptors (34) 
phagocytes also sample their load with Toll-like receptors (TLRs) to determine what they 
are consuming (1).  
 Once a foreign body is recognized by receptors it is internalized through an actin 
dependent process. While the specific proteins vary depending on the receptor, the 
mechanism of phagosome formation and engulfment through each receptor is similar 
(Figure 1-1) and involves signaling Rho family GTPases that recruit actin nucleation 
factors (70, 109). Actin polymerization and branching, through the recruitment of 
Wiscott-Aldrich syndrome protein (WASP) and actin-related protein 2/3 (Arp2/3) then 
drives the creation of the phagocytic cup, which is the initial membrane extrusion of 
pseudopodia used to surround the target. Phagocytosis, especially of larger particles, 
requires extra membrane that is supplied by recycling endosomes, late endosomes and the 
endoplasmic reticulum; the extra membrane is required to protrude pseudopodia for 
surrounding the target. Myosin motors are also recruited to nascent phagosomes, and are 
required for the extrusion of pseudopodia and contraction of the phagocytic cup into the 
phagocyte (3, 23, 74). Other factors such as phosphatidylinositol (PI) kinases are 
recruited to the phagocytic cup, phosphorylate PI and are required for timing actin 
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Figure 1-1. B
acteria are destroyed by m
acrophages through the process of 
phagocytosis and phagosom
e m
aturation. Briefly, phagocytic surface receptors are 
engaged by ligands on the bacterial surface. Engulfm
ent is orchestrated by R
ho G
TPases and 
is an actin dependent action. After engulfm
ent, R
ab G
TPases and phosphotidylinositol-3 
kinase orchestrate m
aturation of the phagosom
e into a m
ature phagolysosom
e. The 
phagolysosom
e is an extrem
ely acidic and hydrolytic com
partm
ent capable of degrading m
ost 
bacteria. 
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polymerization and depolymerization (34). Coronin is a protein required for efficient 
phagocytosis in the amoeba Dictyostelium discoidium (64). Mammalian Coronin 1A also 
localizes to the nascent phagosome in phagocytic cells, but mammalian Coronin is 
apparently expendable in phagocytosis, although it may play an alternate role in 
phagosome maturation (52).  
 While the processes between phagocytosis through different receptors are 
synonymous, it is likely that the final composition of the mature phagosome and/or the 
kinetics of maturation depend on what route the target entered the cell (2).  
 
1.5- Phagosome maturation 
While many of the details are yet to be elucidated, there is a basic framework for 
how phagosome maturation progresses. The kinetics, pathway of maturation, and final 
phagosome composition depend on the cargo to be destroyed. For example, even though 
both types of loads get degraded in the phagolysosome, bacterial loads lead to efficient 
MHC-II peptide loading, whereas peptides from apoptotic cells do not get loaded into 
MHC-II (58). The different outcomes result in inflammation and antigen presentation for 
bacterial loads, whereas apoptotic “self” loads lead to anti-inflammatory phagocytosis 
without antigen presentation.  
After engulfment of the phagocytic load, the Rab GTPase Rab5 is quickly 
recruited to the phagosome (103). This Rab5+ compartment acidifies slightly from pH 7 
to a pH of about 6.1-6.5 and is referred to as a sorting endosome. The sorting endosome 
is called such because it has multiple potential outcomes. The sorting endosome can enter 
the recycling endosome network and be exocytosed.  Alternatively, the sorting endosome 
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can enter the trans-golgi network where proteins are sorted for secretion, surface 
localization, or inclusion in endosomal or lysosomal compartments (34).  The final 
possibility is that the sorting endosome can traffic to a mature phagolysosome.  As it is 
the most relevant to this thesis, we will limit our discussion of these various outcomes to 
that of phagoslysosome maturation.  
For phagolysosome maturation, active (i.e. GTP bound) Rab5 goes on to recruit 
Vps34, a phosphotydlinositol 3-kinase (PI3K) that coats the phagosomal membrane with 
phosphotydlinositol 3-phosphate (PI(3)P). The PI(3)P on the phagosomal membrane in 
turn recruits proteins containing FYVE domains, including the early endosome antigen 1 
(EEA1). Antibodies against EEA1 microinjected into macrophages block phagosome 
maturation, suggesting a role for EEA1 in the maturation process (40). EEA1 is thought 
to be involved in orchestrating fusion events between the early phagosome and endocytic 
vesicles, but its exact role in maturation is not known (34).  
An additional role for Rab5 is the recruitment of another Rab GTPase, Rab7, to 
the maturing phagosome. In model bead and apoptotic corpse phagosomes, Rab7 
recruitment requires active Rab5 and it occurs efficiently without PI3K activity (57, 103). 
Thus, there appears to be a Rab5 dependent mechanism, other than promoting PI(3)P 
deposition, that is required for Rab7 recruitment to the phagosome. Indeed, in the 
maturation of phagosomes containing apoptotic corpses active Rab5 recruits active (i.e. 
GTP bound) Rab7 through the Mon1a-Ccz1 protein complex (57). However, it is not yet 
known whether Rab7 recruitment is through the same mechanism on bacteria-containing 
phagosomes. 
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Active Rab7 in turn interacts with Rab7 Interacting Lysosomal Protein (RILP) 
(17). RILP acts as a scaffold to link Rab7 to Dynamin/Dynactin, which are motor 
proteins that move along tubulin (54). This interaction suggests a model where activated 
Rab7 links the phagosome to the tubulin network in order to drive the phagosome 
movement toward lysosomes for fusion events to occur. Lysosomes are the terminal 
compartment to fuse with phagosomes during the maturation process, once fused to the 
phagosome the combined compartment is referred to as the phagolysosome (35). 
Lysosomes are vacuoles that contain high concentrations of hydrolytic enzymes and 
maintain a very low pH (~4.5) via a high concentration of V-ATPase in their membrane. 
It should be noted that while lysosomes deliver a large quantity of V-ATPase to the 
phagosome, V-ATPase is also delivered to the phagosome throughout the process of 
maturation (34). Lysosomal fusion is thought to be orchestrated by the multi-protein 
homotypic fusion and vacuole sorting (HOPS) complex, which assembles on the 
phagosomal membrane and is directly involved in activating lysosome fusion events (29). 
Toll-like receptors (TLRs) may play a role in fast-tracking phagosomes for 
maturation (5, 10), suggesting an attractive model for how the load is recognized and 
directed by the phagocyte. However, there is some debate and further research will be 
required to tease out the function of TLRs in driving phagosome maturation (108). 
 
1.6- M. tuberculosis phagosomes 
For most bacteria, macrophage phagocytosis results in trafficking to highly 
destructive phagolysosomes where the bacterial cell is destroyed. Once degraded, 
bacterial antigens can be loaded into MHC and presented on the surface of the 
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macrophage (34). For intracellular bacterial pathogens to survive phagocytosis they need 
to have a mechanism to either withstand the phagolysosome environment or a way to 
redirect the trafficking of the phagosome to avoid the compartment altogether.  
 Over the years it has been shown by many different groups and readouts that in 
non-activated macrophages M. tuberculosis avoids trafficking to mature phagolysosomes 
(4). The different approaches used to demonstrate blockage of phagosome-lysosome 
fusion by M. tuberculosis include electron microscopy, fluorescent dextran trafficking, 
and staining for markers of lysosomal fusion such as lysosome associated membrane 
protein-1 (LAMP-1), CD-63, and lysobisphosphatidic acid (LBPA) (4, 61, 62). Further, 
LysoTracker and ratiometric fluorescent dyes have been used to demonstrate M. 
tuberculosis blockage of phagosome acidification (77, 93, 95). However, the mechanism 
employed by M. tuberculosis to avoid phagosome maturation remains elusive. Numerous 
putative M. tuberculosis effectors of phagosome maturation, both lipid and protein, have 
been identified through direct testing and mutant screens (15, 26, 41, 49, 56, 62, 77, 95, 
98-100, 104). However, the mode of action for nearly all of these putative effectors 
remains unknown. What appears to be true from these studies is that the process is likely 
to be multi-factorial and complex and that M. tuberculosis has effectors that disrupt 
phagosome maturation from the beginning (phagocytosis) to the end (lysosomal fusion) 
of the process.  
 
1.7- M. tuberculosis phagocytosis 
 Macrophages recognize M. tuberculosis through several receptors including the 
complement receptors CR1 and CR3, mannose receptor (MR), and scavenger receptors 
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(30). There is evidence that the initial event allowing M. tuberculosis to control 
intracellular trafficking occurs at the step of recognition by a macrophage receptor (55).  
M. tuberculosis can be directly recognized by complement receptor CR3 on the 
macrophage by a complement independent mechanism. This recognition, in the absence 
of the C3b component of complement, occurs at one of two binding sites on CR3 (24). 
Binding at both CR3 sites is required for activation of some antimicrobial activities of 
natural-killer cells and neutrophils (101). Thus, M. tuberculosis may be affecting the host 
cell response early on by limiting binding to one site on the CR3 receptor.  
M. tuberculosis can also be recognized by the host cell through the MR, which 
recognizes the M. tuberculosis surface glycolipid mannose capped lipoarabinomannan 
Man-LAM (87-89).  When MR recognition of ManLAM-coated beads or M. tuberculosis 
is blocked by preincubation with mannan or anti-MR antibody, phagosome maturation 
kinetics are faster. Similarly, when beads or M. tuberculosis are shuttled through the Fcγ 
receptor instead of MR by IgG opsonization, phagosome maturation kinetics are faster.  
These experiments suggest that M. tuberculosis may selectively enter through the MR-
mediated phagocytosis in order to delay phagosome maturation. However, the 
experiments testing the kinetics of phagosome maturation in these different conditions 
were very short, two hours post phagocytosis for bead experiments and 30 minutes post 
phagocytosis for bacteria assays, which is of questionable relevance in a long-term 
chronic infection such as TB (55). This data suggests an important role for receptor 
selection in the early kinetics of phagosome maturation arrest.  
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1.8- M. tuberculosis phagosome maturation 
 Once in a macrophage, the M. tuberculosis-containing phagosome stalls at a 
slightly acidic Rab5+ compartment similar to a sorting endosome. The M. tuberculosis-
containing phagosome is slightly more acidic than a nascent phagosome at a pH of ~6.4 
like a sorting endosome instead of pH 7.0, but far from the pH of a mature 
phagolysosome ~4.5 (82).  Rab5 is an example of a protein that is recruited normally to 
the M. tuberculosis-containing phagosome but is retained, which is unusual.  Not only 
does the M. tuberculosis-containing phagosome retain Rab5 (102), interestingly, it also 
remains accessible to surface transferrin receptor (20), indicating continued interaction 
with recycling endosomes that shuttle cargo between sorting endosomes and the cell 
membrane (35).  
Another example of an abnormally retained protein is Coronin-1A, which is 
recruited normally to M. tuberculosis-containing phagosomes but is retained on the 
surface of a M. tuberculosis-containing phagosome after the phagosome is sealed (32). 
This is unique to M. tuberculosis-containing phagosomes; Coronin-1A is usually released 
from phagosomes after sealing. 
 Model phagosomes quickly build up PI(3)P on the phagosomal surface as part of 
the maturation process. Vps34 is the PI3K that is responsible for the build up of PI(3)P 
on the phagosome. Vps34 is recruited to the phagosome by active Rab5, thus localization 
of Rab5 at the phagosome is required for PI(3)P deposition. However, even though Rab5 
is retained on M. tuberculosis and M. bovis BCG-containing phagosomes, mycobacteria 
clear PI(3)P from the phagosomal surface as shown by studies with BCG-containing 
phagosomes (99).  This effect is important because PI(3)P is required for phagosome 
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maturation through the recruitment of EEA-1, which is thought to orchestrate phagosome 
fusion events with endocytic vesicles. 
 A notable protein that is excluded from the M. tuberculosis-containing 
phagosomes is Rab7 (102).  The absence of Rab7 is significant in that without Rab7, 
RILP recruitment and thus phagosome-lysosome fusion are blocked. By blocking 
lysosomal fusion, M. tuberculosis resists delivery of hydrolytic activity that could be 
damaging to the bacterial cell or restrict growth.  
     
1.9- M. tuberculosis effectors of phagosome maturation arrest 
Exactly how M. tuberculosis arrests phagosome maturation is unclear. What is 
clear from studies of the phenomenon is that it is a complex process that seemingly 
involves a wide range of protein and lipid effectors. Phagosome maturation arrest by M. 
tuberculosis likely includes, but is probably not limited to, selecting specific phagocytic 
receptors used for uptake (55), interfering with PI(3)P signaling on the phagosomal 
surface (40, 98, 99), deactivating Rab GTPases or preventing their acquisition (96), and 
retaining Coronin-1A on the phagosomal membrane (52).  
A small subset of M. tuberculosis protein and lipid molecules have been directly 
tested for their ability to impact phagosome maturation and signaling. Interestingly, some 
of these directly tested effectors may also have essential functions in the bacteria 
unrelated to their proposed moonlighting role in phagosome maturation arrest (26, 104). 
Below we review the list of candidate M. tuberculosis molecules implicated in 
phagosome maturation arrest.  These candidate effectors are presented in order of the 
steps in phagosome maturation in which they are proposed to act.  
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 The following sections describe several experiments involving multiple 
techniques and experimental settings. One of the more common experimental approaches 
used is to compare model phagosomes where the phagocytic particle is a latex bead to 
phagosomes with latex beads coated with a M. tuberculosis molecule to assess the impact 
of that molecule on the phagosome maturation process. Other experiments use 
Escherichia coli or non-pathogenic M. smegmatis as the phagocytic particle, which traffic 
to a mature phagosome after phagocytosis. In these latter experiments, a candidate M. 
tuberculosis effector is ectopically expressed by M. smegmatis or the host cell to assess 
its potential to affect phagosome maturation.  In addition, some experiments utilize M. 
bovis BCG as a surrogate for M. tuberculosis.  Like M. tuberculosis, BCG is able to block 
phagosome maturation, but has the benefit of being non-pathogenic, so it can be used in a 
BSL-2 laboratory.  
 
Mannose-capped lipoarabinomannan (ManLAM) 
 
ManLAM is a surface localized glycolipid of M. tuberculosis.  ManLAM is 
reported in two separate studies to influence phagosome maturation. Phagosomes 
containing ManLAM-coated beads have reduced phagosome-lysosome fusion at early 
time points in phagocytosis assays compared to unconjugated beads, human serum 
albumin-coated beads, or M. smegmatis LAM-coated beads (41, 55). It is possible that 
ManLAM affects phagosome maturation via receptor selection. The reduction in 
phagosome maturation depends on the mannose cap that causes recognition of the 
molecule by the mannose receptor on phagocytes (55). Consistent with these results, M. 
tuberculosis containing phagosomes more readily fuse with lysosomes when 
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phagocytosis through the MR is blocked by preincubation of macrophages with excess 
mannan prior to infection (55). In fact, phagosome maturation occurs more quickly when 
M. tuberculosis or ManLAM coated beads uptake is skewed to phagocytosis through 
receptors other than the mannose receptor, such as the Fcγ receptor via opsonization with 
IgG. Kang et al. conclude that the effect of ManLAM on phagosome maturation is caused 
by skewing uptake of the bacteria through the MR (55).  
   
Phosphotidylinosotol mannoside (PIM) 
 
 PIM is another surface localized glycolipid of M. tuberculosis. PIM is 
additionally reported to be released by M. tuberculosis and to traffic out of the 
phagosome (8). Compared to uncoated beads, phagosomes containing beads coated with 
PIM acidify less and accumulate transferrin receptor, a hallmark of M. tuberculosis-
containing phagosomes. However, in vitro fusion assays show that PIM does not block 
late endosomal fusion events but rather, stimulates fusion of early endosomes with 
recycling endosomes. The interaction of M. tuberculosis-containing phagosomes with 
recycling endosomes is thought to be important for delivering nutrients to the bacteria 
(100). The data suggests that the role of PIM is to maintain a productive interaction with 
recycling endosomes as opposed to preventing interactions with late endosomes. 
  
Lipoamide dehydrogenase (LpdC) 
 
 LpdC is an essential protein in M. tuberculosis probably due to its predicted 
metabolic function as part of the pyruvate dehydrogenase complex that converts pyruvate 
into acetyl-CoA (85). Surprisingly, despite the need for this protein to be cytoplasmic in 
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order to carry out its predicted essential function and the lack of an N-terminal signal 
sequence for export on LpdC, this protein is reported to be secreted by M. tuberculosis 
(65).  
 The unexpected connection between LpdC and phagosome maturation came when 
LpdC was pulled down by immunoprecipitation from BCG infected macrophages with 
antibodies to Coronin 1A (26). As discussed earlier M. tuberculosis-containing 
phagosomes retain Coronin 1A long after it would be released from a model phagosome. 
Compared to wild type J774 macrophages, in J774 macrophages depleted for Coronin 1A 
through siRNA, BCG-containing phagosomes localize more with LAMP-1, which is a 
marker of late endosomes and lysosomes (52).  Thus, the retention of Coronin on 
mycobacteria-containing phagosomes contributes to phagosome maturation arrest. In the 
amoeba Dictyostelium discoideum, Coronin is known for its function in actin remodeling 
for phagocytosis and cell motility; however, the function of Coronin on M. tuberculosis 
phagosomes in macrophages appears to be independent of actin remodeling. Instead, it is 
reported that Coronin retention on the M. tuberculosis phagosome activates calcineurin, 
which in turn creates a calcium flux that interferes with proper phagosome maturation 
(53).  
 LpdC is shown to bind Coronin 1A in a cholesterol dependent manner, and to 
maintain Coronin 1A at the phagosomal membrane. While the lpdC gene is essential and 
cannot be deleted, when the M. tuberculosis lpdC gene is introduced into M. smegmatis it 
imparts M. smegmatis with the ability to retain Coronin-1 on the phagosome. However, 
the study did not determine if M. tuberculosis LpdC imparted the ability to arrest 
phagosome maturation. This recombinant M. smegmatis does show increased 
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intracellular survival in a short macrophage infection (26). These data suggest that the 
predicted metabolic enzyme LpdC is moonlighting as a phagosome maturation arrest 
effector in M. tuberculosis.  
 
Secreted acid-phosphatase (SapM) 
 
 SapM is a secreted M. tuberculosis acid-phosphatase with activity over a wide 
range of pH (5.5 to 8.0) (84). SapM contains a standard N-terminal Sec signal peptide, 
indicating it is likely secreted through the general secretion (Sec) machinery (84).  
 SapM has phosphatase activity on PI(3)P in vitro (99). As mentioned above, 
PI(3)P is an important signaling molecule on the surface of the phagosome and it is 
required for efficient phagosome maturation. Indeed, in experiments where SapM activity 
was inhibited in BCG infected macrophages, PI(3)P was acquired more quickly on the 
phagosomal membrane than in untreated cells, suggesting that SapM does have a role in 
preventing or slowing phagosome maturation (99). However, this experiment used 
molybdate to inhibit SapM, which is a broad inhibitor of phosphatases and likely has 
pleiotropic effects. Further study is still required to clarify the importance of SapM in 
phagosome maturation arrest.   
 
Nucleoside diphosphate kinase (NdkA) 
 
 NdkA is like LpdC in being another M. tuberculosis protein that is predicted to 
have a metabolic function in the bacterial cytosol, in this case phosphorylating nucleoside 
diphosphates (NDPs) to create nucleoside triphosphates (NTPs). The experiments of Sun 
et al. argue for an additional function of NdkA in blocking phagosome maturation (96). It 
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is worthwhile to point out, however, that standard Ndk activity has not been 
demonstrated with NdkA. Instead, Ndk activity has been demonstrated for the M. 
tuberculosis adenylate kinase (Adk) protein. The M. tuberculosis NdkA protein has been 
shown to have phosphatase activity against GTP producing GDP (96). Rab5 and Rab7 are 
important host proteins for phagosome maturation and both require GTP for activity. 
When bound to GDP, Rab5 and Rab7 are inactive. M. tuberculosis NdkA has been shown 
to act on GTP that is bound to Rab5 or Rab7, suggesting it could act directly on the GTP-
bound forms in vivo (96). 
 Despite lacking a signal sequence NdkA is reported to be secreted by M. 
tuberculosis and BCG grown in culture. Compared to wild type, a BCG strain depleted of 
NdkA by an antisense knock-down method is enriched in mature phagosomes four hours 
post-infection, indicating that NdkA plays a role in preventing phagosome maturation. 
The same BCG knockdown strain has decreased survival in macrophages compared to 
wild type indicating an important role for NdkA for the bacteria during intracellular life 
(96). 
 
Protein kinase G (PknG) 
 
 PknG is a protein kinase that has been shown to phosphorylate serine residues on 
a peptide substrate in vitro (59). Based on results from testing a M. tuberculosis pknG 
mutant in a mouse model, PknG is clearly important for M. tuberculosis infection (22).  
However, the specific function of PknG is controversial as a result of two contrasting 
studies.   One study reports PknG to function in blocking phagosome maturation through 
an unknown process (104). PknG is found to be secreted at low levels (22), and even 
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detected in the cytoplasm of BCG infected host cells (104).  The secreted nature of PknG 
is consistent with the protein being an effector secreted into the host cytoplasm. 
Additionally, M. smegmatis engineered to express M. tuberculosis PknG acquires the 
ability to block phagosome-lysosome fusion, as evidenced by decreased LAMP-1 
localization to phagosomes containing the PknG expressing recombinant strain compared 
to wild type M. smegmatis. Additionally, compared to BCG expressing wild type PknG, 
BCG carrying a kinase dead allele of PknG was found more readily in LAMP-1 positive 
phagosomes, indicating an important role for PknG and its kinase activity in blocking 
phagosome maturation (104).   In contrast to these above data, a second study, which 
used a pknG mutant of M. tuberculosis suggests a completely different role for PknG 
during infection. M. tuberculosis pknG mutants are slow growing and levels of glutamine 
and glutamate build up in the mutant, suggesting a role for PknG in amino acid 
metabolism (22).  
 
Protein tyrosine phosphatase (PtpA) 
 
 PtpA is a tyrosine phosphatase of M. tuberculosis that is proposed to act on host 
phosphorylation signaling cascades. Separate studies report roles for M. tuberculosis 
PtpA in either phagocytosis or phagosome maturation arrest. One study found that 
ectopic expression of PtpA in Raw264.7 cells repressed phagocytosis of M. tuberculosis 
and zymosan. Zymosan is yeast cell wall particles often used as model phagocytic targets 
(18). 
 In a second study of PtpA, the phosphatase was shown to dephosphorylate the 
vacuolar protein sorting-associated protein 33B (VPS33B). VPS33B is a component of 
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the multi-protein homotypic fusion and vacuole sorting (HOPS) complex. The HOPS 
complex assembles on the phagosomal membrane and is directly involved in activating 
lysosome fusion events (29). In an in vitro vesicle fusion assay, addition of active PtpA 
and VPS33B together, but not individually, reduced fusion events (6), suggesting that 
PtpA activity on VPS33B is important for blocking vesicle fusion.  
In a third study of PtpA, a connection between PtpA and V-ATPase was 
identified.  Lysosomes maintain a high concentration of V-ATPase in their membranes. 
When expressed ectopically by the host cell PtpA binds to the H subunit of V-ATPase 
and prevents lysosome fusion with E. coli-containing phagosomes. This block in 
phagosome-lysosome fusion requires both binding to V-ATPase and the phosphatase 
activity of PtpA (106). PtpA appears to be involved in blocking the final step of 
phagosome maturation, phagosome-lysosome fusion, and thus protects the bacteria from 
destruction by the hydrolytic mature phagolysosome. Interestingly, PtpA appears to affect 
phagosome maturation and survival in human cell lines, but not in mice, suggesting a 
host specific effect of PtpA (6, 45, 106).  
 
Other candidate effectors of M. tuberculosis phagosome maturation arrest 
 
 Four independent transposon mutant screens of M. tuberculosis and M. bovis 
BCG have produced lists of genes that when mutated result in failure to prevent 
phagosome maturation.  However, there is strikingly little overlap between the genes 
identified in the various phagosome maturation mutant screens (15, 62, 77, 95). The 
differences between these screens remain to be resolved but they may lie in the different 
mycobacterial strains, cell lines, or readouts of phagosome maturation used.  
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From two of the screens for effectors of phagosome maturation, components of 
the ESX-1 specialized secretion system have been shown to be required for phagosome 
maturation arrest (14, 62). ESX-1 has long been known to be required for virulence, but 
how ESX-1 is involved in virulence remains unknown. Phagosome maturation arrest may 
be part of the ESX-1 system’s role in virulence. Lipid metabolic genes are another 
category of commonly identified genes in these screens, possibly due to the role of LAM, 
PIM and potentially other lipids in phagosomal trafficking. Interestingly, three of the four 
screens picked up genes directly involved in the molybdopterin biosynthetic pathway. 
Molybdopterin is an enzyme cofactor that is used by bacteria in carbon, nitrogen, and 
sulfur metabolism. M. tuberculosis and M. bovis have an expanded set of molybdopterin 
biosynthetic genes compared to M. smegmatis suggesting potential importance in 
virulence (105). It is possible that there is an effector of phagosome maturation that uses 
molybdopterin as a cofactor. In addition to a role in phagosome maturation arrest, 
molybdopterin biosynthetic genes have elsewhere been implicated in virulence in diverse 
animal models such as: monkeys, mice, and human cell lines (16, 28, 83).  
 
1.10- M. tuberculosis modulation of other innate immune responses 
M. tuberculosis inhibition of host cell apoptosis 
 
 Another mechanism M. tuberculosis employs to promote replication in 
macrophages is to avoid host-protective apoptosis.  This effect skews host cell death 
toward necrosis, which has the effect of promoting cell-to-cell spread of M. tuberculosis. 
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Figure 1-2. M
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aturation. Through a 
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aturation at a very 
early stage. Several bacterial com
ponents have predicted roles in blocking 
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e m
aturation. The M
. tuberculosis effectors of phagosom
e m
aturation 
include both protein and lipid-based m
olecules.  
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Further, apoptosis is shown to be a mechanism macrophages can use to kill or contain 
mycobacteria (27, 39, 67). These studies demonstrate a correlation between apoptosis and 
reduced intracellular replication or even killing of mycobacteria. In addition to the innate 
role of apoptosis in clearing bacterial infection, increased apoptosis can help establish a 
more robust adaptive immune response by antigen presentation via apoptotic corpses 
leading to better control of M. tuberculosis (48).  
There are a few proposed mechanisms for how M. tuberculosis limits host cell 
apoptosis. One mechanism involves blocking apoptosis caused by the extrinsic pathway. 
The extrinsic pathway refers to apoptosis caused by a signal external to the dying cell. 
TNF-α is a potent signal for initiating the extrinsic pathway. One study shows that M. 
tuberculosis infected macrophages increase secretion of TNF-α receptor2 (TNFR2), as a 
result of increased IL-10 production, which titrates up active TNF-α and prevents 
apoptosis induction through the extrinsic pathway (7). A second way M. tuberculosis 
inhibits apoptosis is through repression of reactive oxygen species (ROS). ROS are 
potent regulators of apoptosis through both the extrinsic and intrinsic pathways (92). One 
study shows that the M. tuberculosis NADPH dehydrogenase NuoG prevents TNF-α 
mediated (extrinsic) apoptosis by reducing the ROS response to infection (66).  
 
M. tuberculosis inhibition of host cell inflammatory response 
 
 Another hallmark of M. tuberculosis infection is the dampening of the innate 
immune response. Macrophages have many receptors such as Toll-like receptors that 
detect pathogens and signal the cell to respond accordingly. In general, responding to a 
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bacterial pathogen means a robust cytokine response that signals there is danger, causes 
macrophage activation and coordination of the adaptive immune response.  
 Macrophages infected with M. tuberculosis do mount an innate immune response 
(9). However, that immune response is dampened by live M. tuberculosis, and some 
purified components of the bacteria on their own have the ability to dampen the response 
(38, 68, 71, 72, 75). This effect is important because some of the cytokines influenced by 
M. tuberculosis, specifically TNF-α, IL-6 and RNI, have the ability to control M. 
tuberculosis intracellular replication and activate macrophages. Thus, this dampening of 
cytokine responses could be important to limiting macrophage activation and control of 
M. tuberculosis.  Additionally, because the adaptive immune response is coordinated by 
signals from the innate response, dampening of the innate response can limit the scale 
and effectiveness of the adaptive response so as to make long-term persistence of M. 
tuberculosis possible (9). 
 
1.11- Protein export systems and their role in virulence 
 To facilitate their interactions with the host, bacterial effectors are most 
commonly proteins or lipids that are exported to the bacterial cell surface or released into 
the host environment. In order for proteins to move from their site of synthesis in the 
cytoplasm to the cell wall and beyond, protein export systems are required.  
 
Conserved protein export  
 
One protein export system that is found in all bacteria, is the general Sec protein export 
pathway. This system is used for the bulk of protein export in bacteria and is essential to 
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bacterial life. Preproteins, which contain a N-terminal Sec signal peptide, are exported 
across the cytoplasmic membrane in an unfolded state by the Sec system. Once exported, 
the signal peptide is cleaved and the protein folds into its mature form.  
A central component of the Sec system is the SecYEG integral membrane 
translocon, which serves as the pore through which exported proteins travel across the 
cytoplasmic membrane. In addition to the YEG pore, the SecA ATPase is essential for 
targeting cytoplasmic preproteins to the translocon, and then supplying the energy to 
push the protein through the pore (reviewed in (69, 76)). 
 
Specialized protein export  
 
 The general Sec pathway is important for exporting a wide range of proteins, 
including virulence factors.   However, bacterial pathogens often additionally employ 
specialized secretion systems for the purpose of delivering virulence factors into a host 
cell. Some specialized secretion systems offer mechanisms to deliver proteins directly to 
the host cell cytoplasm making them ideal for effector delivery. Good examples of these 
types of specialized secretion systems are the Type III secretion systems (T3SS) found in 
many pathogens including Salmonella, Pseudomonas, Shigella, and Yersinia (42); and 
the Type IV secretion system used by Legionella (19). Notably, some T3SS and T4SS 
systems are used to affect phagocytosis and phagosome trafficking (42, 50). 
 
M. tuberculosis specialized protein export 
 
 The M. tuberculosis genome is known to encode two types of specialized 
secretion systems: the ESX systems and the SecA2 system (21). In M. tuberculosis, there 
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are five homologous ESX secretion systems (ESX1-5). ESX-1 is important for virulence. 
The ESX-1 system is deleted from the genome of M. bovis BCG, which accounts for 
some of the attenuation of virulence of the BCG vaccine strain (78). In M. tuberculosis, 
ESX-1 protein export is required for virulence in macrophages and mice (37, 46, 94).  
Further, the ESX-1 system is shown to be important for blocking phagosome maturation 
(15, 62), and dampening of the inflammatory response to M. tuberculosis (63, 94). 
However, at this point, neither the mechanism through which ESX-1 performs these 
virulence functions, nor the responsible secreted proteins are known. There are four other 
ESX systems in M. tuberculosis. ESX2-5 are homologous to the ESX-1 system, but are 
predicted to be expendable in virulence (80, 86). 
 The other known specialized secretion system in M. tuberculosis is the SecA2 
accessory Sec pathway (11). Mycobacteria and some Gram-positive bacteria are unique 
in that they have two copies of secA (81). The two gene products are termed SecA1 and 
SecA2.  Each SecA has unique functions. In mycobacteria SecA1 performs the bulk of 
protein export for the cell as part of the general Sec pathway described above; thus, 
SecA1 is essential. In contrast, SecA2 is required for the export of a small subset of 
proteins, and is dispensable for in vitro growth (11).  
 Central to this thesis is the fact that the SecA2 protein export pathway is required 
for full virulence of M. tuberculosis (12, 60). A M. tuberculosis deletion mutant of the 
secA2 gene termed ΔsecA2 is defective for growth in macrophages and in mice (12, 60). 
The thrust of this thesis is to understand the cause of the virulence defect in the ΔsecA2 
mutant and elucidate the role of the SecA2 protein export pathway in M. tuberculosis 
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virulence. To this end, we followed up on phenotypes of the ΔsecA2 mutant in 
macrophages that could possibly account for the role of the SecA2 system in virulence.  
 
The ΔsecA2 mutant induces an increased inflammatory response in infected macrophages 
compared to wild type M. tuberculosis.  In response to infection with the ΔsecA2 mutant, 
macrophages secrete more TNF-α, IL-6, and reactive nitrogen intermediates (RNI) (60). 
These three host molecules are stimulated by M. tuberculosis through the TLR-2/MyD88 
system (13, 51, 79, 90, 91, 97).  Furthermore, TNF-α, IL-6, and RNI are all established as 
being essential for controlling M. tuberculosis replication in the host.  Thus, in Chapter 
Two we explored the possibility that the role of the SecA2 system in virulence is to limit 
protective cytokine responses.  Our results indicated that in the context of macrophages 
and mice, neither MyD88 responses nor TNF-α can account for the ΔsecA2 mutant 
intracellular growth defect. 
 
Second, the ΔsecA2 mutant of M. tuberculosis induces more apoptosis than wild type M. 
tuberculosis in infected macrophages (48).  As mentioned above, M. tuberculosis 
inhibition of apoptosis could promote intracellular replication of the bacillus. Therefore, 
in Chapter Three we examined the role of the increased apoptosis observed with the 
ΔsecA2 mutant to determine if it accounts for the ΔsecA2 mutant intracellular growth 
phenotype. Our results indicate that an effect on apoptosis is also insufficient to explain 
the intracellular replication phenotype of the ΔsecA2 mutant.  Also in Chapter Three we 
tested a role for SecA2 in phagosome maturation arrest and demonstrate for the first time 
that the SecA2 system is required for M. tuberculosis blocking phagosome maturation. 
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The ΔsecA2 mutant resides in phagosomes that are more acidic than phagosomes 
containing wild-type M. tuberculosis. Additionally, the ΔsecA2 mutant-containing 
phagosome show signs of fusion with lysosomes, which wild type M. tuberculosis 
avoids. Finally, by chemically blocking the acidification of the ΔsecA2 mutant-containing 
phagosome we were able to effectively rescue its intracellular growth phenotype. This 
data indicates that the SecA2 export pathway promotes M. tuberculosis replication in 
macrophages by blocking phagosome maturation.   
 
The data presented in Chapter Three suggests that SecA2 is involved in secreting one or 
more effectors of phagosome maturation.  Therefore, in Chapter Four we tested a set of 
candidate effectors of phagosome maturation arrest for evidence of secretion by the 
SecA2 system. We found that SecA2 has an effect on the levels of SapM, a putative 
effector of PI(3)P on the surface of phagosomes.  This intriguing result opens up new 
questions for future research. Can the effect of the SecA2 system on SapM explain the 
role of the SecA2 system in macrophages?  How does SecA2 influence SapM levels?  
This thesis provides a better understanding of how SecA2 promotes M. 
tuberculosis growth in macrophages. Additionally, it demonstrates the importance of 
phagosome maturation arrest for M. tuberculosis virulence.  It is likely that M. 
tuberculosis secretes multiple effectors of phagosome maturation. The phagosome 
maturation phenotype of the ΔsecA2 mutant we show in this thesis indicates there is 
either a single critical effector or multiple effectors that depend on the SecA2 protein 
export pathway. Future studies will continue to work towards identifying the SecA2-
dependent effectors of phagosome maturation arrest, achieving two goals: understanding 
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the role of the SecA2 system in virulence and identifying substrates of the SecA2 protein 
export pathway.  
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CHAPTER II 
 
 
 
 
EXAMINING THE ROLE OF THE INCREASED INFLAMMATORY RESPONSE TO 
THE ∆SECA2 MUTANT OF MYCOBACTERIUM TUBERCULOSIS 1 
  
 
 
2.1- Introduction 
Resident alveolar macrophages are often the first immune cells encountered by 
bacteria that get inhaled into the lung. These macrophages are well equipped to consume 
and digest most bacteria that land in the alveolar spaces of the lung.   However, during 
pulmonary infection, Mycobacterium tuberculosis replicates within these macrophages in 
the lung. In the case of M. tuberculosis infection, it is thought that the bacteria can 
survive and replicate inside macrophages because primary macrophage innate immune 
responses are blocked or dampened by the pathogen (10).  
Macrophages have many receptors such as Toll-like receptors (TLRs) that detect 
pathogens and signal the cell to respond accordingly. In general, responding to a bacterial 
pathogen means a robust cytokine response that signals there is danger, causes 
macrophage activation and coordination of the adaptive immune response. While 
macrophages infected with M. tuberculosis do mount an innate immune response (2), the 
degree of the response is dampened by live M. tuberculosis and even some purified 
components of the bacteria (8, 17-20). The effect of M. tuberculosis on the immune 
                                                
1 Authored by: Jonathan Tabb Sullivan, Ellen F. Young, and Miriam Braunstein 
 44 
response is likely to be important because some of the regulated immunomodulatory 
molecules, specifically TNF-α, IL-6 and reactive nitrogen intermediates (RNI) can 
control M. tuberculosis intracellular replication and induce killing of bacteria in 
macrophages (4, 6). Additionally, dampening of the innate response can affect the 
adaptive response so as to make long-term persistence possible (2). 
TNF-α, IL-6 and RNI are all shown to contribute to the production of a successful 
host response to M. tuberculosis infection in a low dose aerosol mouse model of infection 
(7, 15, 16). In mice defective for TNF-α, IL-6 or RNI M. tuberculosis reaches a higher 
bacterial burden in the lung and the mice die from infection in 40 days as compared to 
~200 days in wild-type C57BL/6 mice (7, 15, 16). The host adapter molecule MyD88 is 
required for TLR signaling responses to M. tuberculosis that include TNF-α, IL-6, and 
RNI responses (reviewed in (11, 12, 21)). Like the mice deficient for TNF-α, IL-6 or 
RNI, in mice lacking MyD88 M. tuberculosis replication during the primary phase of 
infection is unchecked (7, 15, 16, 22) and mice succumb to the infection within 40 days 
of exposure to a low dose (100-200 cfu) of bacteria in the lung.  
 The SecA2 accessory protein export pathway is important for virulence in M. 
tuberculosis (3, 13). A ∆secA2 mutant of M. tuberculosis, which carries an in-frame 
unmarked deletion of the secA2 gene, is defective for growth in cultured primary bone 
marrow derived macrophages and during the acute phase of mouse infection (3, 13). 
During the acute phase of infection, M. tuberculosis replicates in macrophages, which 
links the macrophage growth defect and the in vivo growth defect. In order to understand 
the role of the SecA2 export pathway in M. tuberculosis in macrophages, we previously 
analyzed macrophage responses to infection with the ∆secA2 mutant. Bone marrow-
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derived macrophages infected with the ∆secA2 mutant, compared to the wild type H37Rv 
strain of M. tuberculosis, produce higher levels of TNF-α, IL-6 and RNI indicating a role 
for the SecA2 pathway in dampening the immune response (13). Because all these 
immunomodulatory molecules upregulated in ∆secA2 mutant infected macrophages are 
controlled by MyD88 we proposed that the increased inflammatory response elicited by 
the mutant would depend on MyD88. We also hypothesized that intracellular replication 
of the ∆secA2 mutant was inhibited as a result of increased macrophage production of 
inflammatory cytokines leading to more highly activated macrophages.  In this chapter 
we explored further the role of the increased inflammatory response to the ∆secA2 mutant 
of M. tuberculosis. 
 
2.2- Results 
MyD88 is required for the inflammatory response of macrophages to infection with 
the ∆secA2 mutant.  
 
 M. tuberculosis elicits an innate immune response through TLRs 2, 4, and 9. 
These TLRs signal through the adapter molecule MyD88, although TLR-4 also has a 
MyD88-independent pathway. The ∆secA2 mutant of M. tuberculosis elicits a more 
robust macrophage response than H37Rv, as shown by increased TNF-α, IL-6 and RNI 
production. Because MyD88 is required to induce all three of these immunomodulatory 
molecules in responses to M. tuberculosis, we tested whether the more robust response to 
the ∆secA2 mutant was MyD88 dependent. Because SecA2 has previously been 
demonstrated to export two lipoproteins of M. smegmatis (9), we also tested the role of 
TLR-2 in the inflammatory response.  TLR- recognizes exported lipoprotein agonists. 
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To determine if the increased macrophage response to the ∆secA2 mutant is 
MyD88-dependent, we compared TNF-α and IL-6 levels in supernatants from bone 
marrow macrophages prepared from C57BL/6 or MyD88 deficient (MyD88-/-) mice that 
were infected with H37Rv or the ∆secA2 mutant. In response to infection with H37Rv or 
the ∆secA2 mutant, MyD88-/- macrophages did not produce detectable levels of TNF-α or 
IL-6 (Figure 2-1A). This result indicates that MyD88 is absolutely required for the TNF-
α and IL-6 response to both H37Rv and the ∆secA2 mutant.  Further, this result indicates 
that the more robust response elicited by the ∆secA2 mutant depends on the MyD88 
pathway.  
To determine if TLR-2 is also required for this cytokine response, macrophages 
from TLR-2-/- mice were infected with H37Rv or the ∆secA2 mutant and the level of 
secreted TNF-α was assayed.  Although considerably reduced from what is seen with 
C57BL/6 macrophages, TNF-α secretion was detected from infected TLR-2-/- 
macrophages. Interestingly, 2-fold more TNF-α was produced by TLR-2-/- macrophages 
infected with the ∆secA2 mutant in comparison to H37Rv, which is similar to the 2-fold 
difference in TNF-α levels induced by the same strains with C57BL/6 macrophages 
(Figure 2-1B).  From these experiments, we conclude that TLR-2 signaling occurs in 
response to the ∆secA2 mutant; however, the increased inflammatory response to the 
∆secA2 mutant is not TLR-2 dependent. While these data rule out increased TLR-2 
signaling as the source of the increased inflammatory response to the ∆secA2 mutant, 
they does not rule out the possibility of there being increased signaling through other 
TLRs.  
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Increased TNF-α  does not explain the ∆secA2 mutant growth defect. 
 
Based on our past data showing increased TNF-α production by macrophages infected 
with the ∆secA2 mutant, we hypothesized that the higher levels of TNF-α could be 
responsible for the intracellular growth defect of the ∆secA2 mutant. TNF-α is a pro-
inflammatory cytokine with effects that include activation of antimicrobial activity in 
macrophages and host cell apoptosis.  TNF-α is shown to have a crucial role in 
controlling replication of M. tuberculosis in mice (7). Additionally, TNF-α can work 
synergistically with another mediator (e.g. interferon gamma) to arrest M. tuberculosis 
intracellular replication in cultured macrophages (4, 6). Thus, the higher levels of TNF-α 
elicited by the ∆secA2 mutant could act to control M. tuberculosis replication.  
To determine if the higher TNF-α levels are responsible for the intracellular 
growth defect of the ∆secA2 mutant, we compared bacterial replication in macrophages 
from TNF-α-/- and C57BL/6 mice infected with H37Rv or ∆secA2 mutant M. 
tuberculosis.  If the increased level of TNF-α observed in ∆secA2 mutant infected 
macrophages is the cause of the intracellular growth phenotype, removing TNF-α from 
macrophages should abrogate the ∆secA2 mutant growth phenotype.  These experiments 
demonstrated the ∆secA2 mutant growth defect is not recovered in TNF-α-/- macrophages 
when compared to C57BL/6 macrophages (Figure 2-2A).  Thus, elevated levels of TNF-
α do not explain the ∆secA2 mutant intracellular growth defect.  
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Figure 2-1. M
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ere infected for 24 
hours at an M
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I of 1:1 w
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utant, supernatants collected and 
assayed for cytokine levels. A representative experim
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levels w
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57BL/6 or M
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88
-/- m
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F-α levels w
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57BL/6 or TLR
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-/- m
acrophages. Bars show
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pared to H
37R
v in C
57BL/6 m
acrophages, by Student’s t test. 
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A MyD88 dependent response to the ∆secA2 mutant does not explain the growth 
defect.  
 
As another way to determine if the more robust innate response to the ∆secA2 
mutant is responsible for the mutant’s attenuation, we infected macrophages from 
MyD88-/- mice.  As mentioned above, our prior studies identified three 
immunomodulatory molecules that are increased in macrophages infected with the 
∆secA2 mutant and all are known to be under the control of MyD88.   Further, we 
showed MyD88-/- macrophages fail to produce detectable levels of TNF-α and IL-6 in 
response to M. tuberculosis (Figure 2-1).  However, the central role of MyD88 in TLR 
and IL-1β signaling makes MyD88-/- mice more broadly defective in innate immune 
response signaling.  Therefore, if the ∆secA2 mutant elicits more MyD88-dependent 
signaling in macrophages then there may be MyD88-dependent factors, other than TNF-
α, that are responsible for the intracellular growth phenotype of the ∆secA2 mutant.  To 
test this possibility we infected macrophages from MyD88-/- mice.  If the ∆secA2 mutant 
intracellular growth defect is due to a more robust MyD88-dependent response to M. 
tuberculosis, then the ∆secA2 mutant phenotype should be abrogated and the mutant 
should behave like H37Rv in MyD88-/- macrophages.   
 Like in the TNF-α-/- macrophages, the ∆secA2 mutant remained defective for 
growth in MyD88-/- macrophages when compared to H37Rv (Figure 2-2B). These data 
indicate that, at least on its own, a MyD88-dependent inflammatory response to the 
∆secA2 mutant is not responsible for the intracellular growth defect.  
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The ∆secA2 mutant is attenuated in mice even in the absence of TNF-α  or MyD88. 
 
The above experiments were performed with cultured macrophages in a single cell 
system.  We tested the importance of TNF-α and MyD88-dependent immune responses 
to phenotypes of the ∆secA2 mutant in a whole animal in vivo model of infection. In this 
model, mice are infected with approximately 200 cfu/lung using a whole body aerosol 
delivery system (Madison Aerosol Chamber). Over time, we monitored bacterial burden 
in the lungs of infected mice to determine rate of bacterial growth in the lung. In this 
model, H37Rv grows from ~200cfu/lung to ~1 x 107 cfu/lung during the first three weeks 
of infection. The initial growth phase is followed by a persistence phase in which an 
antigen specific TH1 response causes the lung burden to plateau and maintain 
homeostasis for the remainder of the infection. The ∆secA2 mutant has a growth defect 
during the first three weeks and reaches a lower final burden of ~1 x 106 cfu/lung (3). At 
three weeks, post-infection the ∆secA2 mutant still enters a persistence phase and the 
lung burden maintains homeostasis through the rest of the infection.  
To determine if TNF-α and MyD88 are involved in the ∆secA2 mutant’s 
attenuation in vivo, we infected C57BL/6, TNF-α-/-, or MyD88-/- mice with H37Rv or the 
∆secA2 mutant. If the ∆secA2 mutant is defective for growth in mice because it fails to 
repress TNF-α or MyD88-dependent immune responses, then infection of mice lacking 
these regulatory molecules will abrogate the attenuated phenotype.  Both TNF-α-/- and 
MyD88-/- mice are highly susceptible to M. tuberculosis infection (7, 22). When infected 
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Figure 2-2. The ∆secA2 mutant remains attenuated in macrophages 
lacking TNF-α  or MyD88. A. C57BL/6 or TNF-α-/- macrophages infected 
with wild type or the ∆secA2 mutant and monitored for intracellular 
replication over five days. Shown is a representative experiment of three. 
Points are means of triplicate wells +/- SD. *p ≤ 0.05 as determined by 
Student’s t test. C. C57BL/6 or MyD88-/- macrophages infected with wild 
type or the ∆secA2 mutant and monitored for intracellular replication over 
five days. Shown is a representative experiment of three. Points are means 
of triplicate wells +/- SD. *p ≤ 0.05 as determined by Student’s t test. 
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with M. tuberculosis, compared to C57BL/6, both TNF-α-/- and the MyD88-/- strains of 
mice have 10-100 fold higher lung burdens at the three-week time point. This is due to 
the failure to establish TH1 control of the infection as normally occurs by the three-week 
timepoint, and both mouse strains succumb to infection within 40 days of exposure as 
opposed to the 200 day timepoint.  
 We infected TNF-α-/- or MyD88-/- mice with wild type or the ∆secA2 mutant of M. 
tuberculosis. We then assayed bacterial burden in the lungs of mice over a three-week 
period. The experiments demonstrated that even in TNF-α-/- or MyD88-/- animals, the 
∆secA2 mutant exhibited a replication defect compared to H37Rv (Figure 2-3). These 
data do not support a role for TNF-α or MyD88 in the ∆secA2 mutant in vivo growth 
defect.  These results also reinforce the results from testing the strains in macrophages.   
 
2.3- Discussion 
 The ∆secA2 mutant has an intracellular growth defect, and elicits an increased 
inflammatory response from macrophages compared to H37Rv. In this study we tested 
whether the increased inflammatory response to the ∆secA2 mutant is the cause of the 
mutant’s intracellular growth defect. Using macrophages derived from TNF-α-/- and 
MyD88-/- mice and the mice themselves, we determined if elevated MyD88-dependent 
responses, or TNF-α in particular, account for the ∆secA2 mutant intracellular and in vivo 
growth defects.   
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Figure 2-3. The ∆secA2 mutant remains attenuated in mice lacking 
TNF-α or MyD88. A. Lung burden of C57BL/6 or TNF-α-/- mice infected 
via aerosol with H37Rv or ∆secA2 mutant M. tuberculosis. Points 
represent mean lung burden from four animals +/- SD. *p ≤ 0.05 
compared to H37Rv by Student’s t test. B. Lung burden of C57BL/6 or 
MyD88-/- mice infected via aerosol with H37Rv or ∆secA2 mutant M. 
tuberculosis. Points represent mean lung burden from four animals +/- 
SD. *p ≤ 0. 05 compared to H37Rv by Student’s t test.  
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First, we showed that the ∆secA2 mutant did not elicit a detectable TNF-α or IL-6 
response in MyD88-/- macrophages.  This result reinforces past reports of MyD88 being 
required to elicit these responses to M. tuberculosis.  In addition, our results showed that 
MyD88 is essential for the ∆secA2 mutant response.  We further showed that in TLR-2-/- 
macrophages the TNF-α response was reduced to both H37Rv and the ∆secA2 mutant 
when compared to C57BL/6 macrophages, but that there was still a significant difference 
in TNF-α elicited by the ∆secA2 mutant versus H37Rv.   Thus, we conclude that the 
cause of the increased inflammatory response to the ∆secA2 mutant is TLR-2 
independent, although TLR-2 does amplify the amount of TNF-α produced in response to 
both H37Rv and the ∆secA2 mutant. Recently, a hip1 mutant of M. tuberculosis was 
reported to induce more robust MyD88-dependent responses by macrophages.  However, 
in the case of hip1, it appears that the more robust immune response observed with the 
mutant is TLR-2 dependent, suggesting the mutant elicits increased TLR2 signaling to 
achieve this effect.  
In assessing the significance of the increased immune responses of ∆secA2 mutant 
infected macrophages, we found that the ∆secA2 mutant has an intracellular growth 
defect even in macrophages derived from MyD88-/- and TNF-α-/- mice. These 
macrophage experiments revealed that TNF-α and MyD88 are not required to control the 
intracellular growth of the ∆secA2 mutant. However, it is important to point out that we 
do not know the scope of the increased inflammatory response and there may still be 
important MyD88-independent factors. With this caveat in mind we can only rule out 
MyD88-dependent inflammation in the ∆secA2 mutant growth defect. 
 55 
In addition to the macrophage growth assays we performed mouse infections in 
TNF-α-/- and MyD88-/- mice. The growth of the ∆secA2 mutant in these mice 
recapitulated the macrophage results that showed that the ∆secA2 mutant phenotype was 
not rescued in either the TNF-α-/- of MyD88-/- mice. Thus, we conclude that there must be 
other factors besides dampening MyD88 responses that the SecA2 system is doing to 
promote growth in macrophages and mice. 
 Earlier, our laboratory had obtained preliminary data from testing the ∆secA2 
mutant in MyD88-/- and TNF-α-/- macrophages that led to the opposite conclusions 
(unpublished results).  In these earlier studies, the mutant phenotype of the ∆secA2 
mutant was not maintained but rescued in MyD88-/- and TNF-α-/- macrophages (14).  We 
believe the most likely explanation for the discrepancy in results is that different batches 
of L-929 cell conditioned media (LCM) were used to differentiate bone marrow cells into 
macrophages in the different experiments.  LCM contains granulocyte monocyte-colony 
stimulating factor (GM-CSF) (5), an important component in stimulating hematopoietic 
stem cells to differentiate into macrophages.  However, LCM is media recovered from 
cells grown in culture and it contains many secreted factors. The composition of LCM 
can vary batch to batch, and different batches could affect bone marrow differentiation 
differently. We do, in fact, see differences in the number of adherent macrophages 
recovered from bone marrow flushed from a femur with different batches of LCM.  The 
batch-to-batch variability could also be influencing the activation status of macrophages 
such that they are more or less sensitive to inflammatory cytokines, which could have 
influenced our experiments. Most importantly, for the macrophage data presented in this 
chapter the results are entirely consistent with the results of testing the mutant in the more 
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relevant whole animal model of infection.  In our studies presented here the absence of 
TNF-α or MyD88 did not influence growth of the ∆secA2 mutant in either cultured bone 
marrow macrophages or murine infection.  These results indicate there must be another 
role for the SecA2 system, besides regulating MyD88 responses, in promoting 
intracellular growth.  
 
 
2.4- Materials and Methods 
Bacterial strains and growth conditions 
 
 In this study we used Mycobacterium tuberculosis wild type strain H37Rv, and 
the ∆secA2 mutant (mc23112) generated in the H37Rv background (3). M. tuberculosis 
strains were cultured in liquid Middlebrook 7H9 media or solid 7H10 supplemented with 
0.05% Tween 80, 0.5% glycerol, 1× albumin dextrose saline (ADS). For plating organ 
homogenates from murine infections, cyclohexamide (10µg/ml) was incorporated into 
7H10 agar to inhibit fungal growth.  
 
Animals 
 
 C57BL/6 mice acquired from Charles River Labs were used in aerosol infections 
and for bone marrow-derived macrophages. MyD88-/- mice on the C57BL/6 background 
(1) were acquired from Dr. Shizuo Akira (WPI Immunology Frontier Research Center, 
Research Institute for Microbial Diseases, Osaka University, Osaka Japan). TNF-α-/- mice 
on the C57BL/6 background were acquired from Dr. Jonathon D. Sedgwick (SP 
Biopharma, Palo Alto, CA). TLR2-/- mice on the C57BL/6 background were acquired 
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from Dr. Carsten Kirsching (Institute of Medical Microbiology, Immunology and 
Hygiene, Technical University Munich, Munich, Germany). All mice were housed in 
sterile caging and provided sterile food and water. All animal protocols were followed 
strictly as approved by the UNC Institutional Animal Care and Use Committee (IACUC). 
 
Aerosol infection and necropsy 
 
 Aerosol infection of mice was performed using a Madison aerosol chamber. Mice 
were exposed to an aerosol generated from M. tuberculosis that was grown to log-phase 
and washed once and resuspended in PBS containing 0.05% Tween 80 at a concentration 
of 1.2 × 107 colony forming units (cfu)/ml. The mice were exposed to aerosols for 15 
minutes with a 20-minute purge to clear the chamber resulting in an approximate dose of 
200 cfu/lung. At various time points mice were euthanized, their lungs homogenized and 
plated for cfu on 7H10 agar to enumerate lung burden.  
 
Making L-929 conditioned media (LCM) 
 
L-929 conditioned media is made by first recovering the L-929 cells from liquid 
nitrogen stocks. A 2 ml aliquot of frozen L-929 cells is thawed as quickly as possible, and 
immediately added to 10 ml of prewarmed complete Dulbecco modified Eagle medium 
(DMEM; Sigma). “Complete” DMEM contains 10% fetal bovine serum (FBS; Gibco), 
2mM L-glutamine, and 1× nonessential amino acids. The cells are then centrifuged at 200 
× g for 5 minutes to pellet cells. The supernatant is decanted and cell pellet resuspended 
in 10 ml complete DMEM to wash. The L-929 cells are then centrifuged at 200 × g for 10 
minutes to pellet cells and wash a second time to remove residual DMSO from the 
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freezing media. After 2 washes the cells are resuspended in 4 ml prewarmed complete 
DMEM and plated in one well of a 6-well tissue culture dish and incubated at 37°C and 
5% CO2. After 24 hours nonadherent cells were washed away and fresh complete DMEM 
added to the well. When the cells grew to confluency, they were lifted from the well with 
1× trypsin-EDTA at 37°C for ten minutes, then washed twice in warm DMEM to remove 
trypsin-EDTA. The cells were split into multiple wells of a 6-well tissue culture dish and 
grown again to confluency. At confluency the cells are again lifted with trypsin-EDTA as 
before, and resuspended at 5 × 103 cells/ml of complete DMEM. The resuspended cells 
were plated with 25 ml on 100 mm × 20 mm tissue culture treated dishes, and incubated 
at 37°C and 5% CO2. The cells were grown until just past confluency (~6-7 days), i.e. the 
monolayer has a cobblestone appearance due to cells starting to round up because of 
crowding. The supernatant is collected, filtered through a 0.22 µm filter, and aliquoted 
for freezing at -80°C. 
 We tested all batches of LCM for mycoplasma contamination by PCR using the 
MycoAlert test kit (Lonza). Using fluorescence activated cell sorting (FACS) we looked 
at surface markers (CD11b, CD11c, MHC-I, MHC-II, and F4/80) to determine the purity 
of our macrophage population i.e. to determine what percent of adherent cells were 
macrophages. After selecting for the adherent population of cells we stained the 
macrophage population with fluorescently conjugated FACS antibodies. Fluorescently 
conjugated antibodies were acquired from eBioscience. FACS was performed on a CyAn 
ADP LX 9 color flow cytometer (Dako) at the UNC FACS core facility. The data were 
analyzed using Summit version 4.3 (Dako). We found that higher concentrations of LCM 
produced higher numbers of adherent cells, so we tested each batch of LCM to determine 
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the best concentration that would produce 3.0 x 107 macrophages from two femurs. For 
all LCM batches tested, >95% of the adherent cells cultured tested positive for 
macrophage surface markers, which were CD11bhigh, CD11clow, MHC-I+, MHC-II+, and 
F4/80high. At lower concentrations of LCM the number of adherent cells was lower, but 
the percentage of macrophages in the adherent population did not change. Even with 
these quality controls, we believe there remains batch-to-batch variation in LCM that can 
affect the outcome of experiments with cultured macrophages. 
 
Macrophage infections 
 
 For bone marrow-derived macrophages, mice were euthanized by CO2 
asphyxiation and cervical dislocation. Femurs were extracted and flushed with complete 
DMEM. Bone marrow cells were washed and resuspended and plated in complete 
DMEM containing 20% L-929 cell conditioned media (LCM). After six days at 37°C, 
5% CO2, the cells were lifted off the plates using cold PBS EDTA 5mM and scraping. 
The cells were then washed twice and resuspended at a concentration of 1 × 106 
macrophages/ml in complete DMEM containing 10% LCM. Macrophages were then 
seeded at 2 × 105 macrophages/well in eight-well chambered slide or chambered cover 
slips for microscopy experiments. 
 After resting 24 hours the macrophages were infected with M. tuberculosis culture 
grown to log-phase, and washed once with PBS containing 0.05% Tween 80 and diluted 
in warm complete DMEM. Macrophages were infected at an MOI of 1.0 or 0.2. After a 
four-hour incubation at 37°C for bacterial uptake, infected macrophages were washed 
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three times with pre-warmed complete DMEM. Macrophages were lysed at various time 
points and lysates were plated for cfu.  
 
Enzyme-linked immunosorbent assay (ELISA) 
 
ELISAs for TNF-α and IL-6 were performed using OptEIA II ELISA (Becton 
Dickinson). Murine bone marrow macrophages were infected at an MOI of 1.0 with 
H37Rv or ΔsecA2 and incubated for four hours at 37°C and 5% CO2, after which the 
extracellular bacteria were washed off with pre-warmed DMEM. The macrophages were 
then let incubate for 24 hours at 37°C and 5% CO2. Then, the supernatants were collected 
and double filtered with 0.22 µm filters. For the ELISA, samples were loaded undiluted 
and at a 1:5 dilution. ELISAs were run as per the kit instructions. 
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CHAPTER III 
 
 
 
 
THE MYCOBACTERIUM TUBERCULOSIS SECA2 SYSTEM SUBVERTS 
PHAGOSOME MATURATION TO PROMOTE GROWTH IN 
MACROPHAGES1 
 
 
 
 
 
3.1- Introduction 
Mycobacterium tuberculosis infects about one-third of the world population and, as the 
infectious agent of tuberculosis, causes almost two million deaths per year (69). With the 
emergence of drug-resistant strains of M. tuberculosis current treatments may soon 
become obsolete, fueling the need for new drugs and more effective vaccines to combat 
the disease.  A better understanding of M. tuberculosis pathogenesis will facilitate efforts 
to develop new tuberculosis control measures.  
Inside the host, M. tuberculosis survives in a unique intracellular niche within 
macrophage phagosomes.  Following its phagocytosis by non-activated macrophages, M. 
tuberculosis arrests the normal process of phagosome maturation.  As a result, M. 
tuberculosis resides in a phagosome that fails to acidify or fuse with late endosomes and 
lysosomes that supply hydrolytic enzymes and antimicrobial peptides (2, 52). This M. 
                                                
1 Adapted for this dissertation from: Sullivan, J. T., Young, E. F., McCann, J. R., & 
Braunstein, M. (2012). The Mycobacterium tuberculosis SecA2 System Subverts 
Phagosome Maturation to Promote Growth in Macrophages. Infect Immun. 
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tuberculosis phagosome resembles an early recycling endosome that is accessible to 
transferrin and maintains a pH of ~6.4 (46). M. tuberculosis containing phagosomes are 
further distinguished by diminished accumulation of vacuolar ATPase (V-ATPase), 
phosphatidylinositol-3-phosphate [PI(3)P], and activated Rab7, which normally 
accumulate on maturing phagosomes (54, 57, 62, 63, 65). While the ability of M. 
tuberculosis to block phagosome maturation is widely thought to play an important role 
in promoting M. tuberculosis intracellular growth, there are few experiments that directly 
address a causal relationship between phagosome maturation arrest and intracellular 
growth. Furthermore, the mechanism M. tuberculosis uses to prevent phagosomes from 
maturing into acidic hydrolytic compartments is not well understood, but appears to be a 
multi-factorial process involving both protein and lipid effectors (3, 8, 14, 21, 36, 46, 56, 
59, 63, 67).  
M. tuberculosis effectors that alter phagosome trafficking will likely be molecules 
that are exported by the bacillus (either secreted or surface localized) and positioned to 
interact with host cell processes. With the intracellular pathogens Legionella and 
Salmonella, specialized secretion systems are used to deliver effectors of phagosome 
trafficking (9, 13).  M. tuberculosis has two types of specialized protein export systems: 
the ESX systems and accessory SecA2 system (16).  The ESX-1 secretion system has 
previously been shown to block phagosome maturation in M. tuberculosis infected 
macrophages (8, 36). Here, we investigated the accessory SecA2 protein export system of 
M. tuberculosis and its role in virulence and phagosome maturation arrest. Mycobacteria 
are unusual in having two distinct SecA ATPase proteins (SecA1 and SecA2) (27, 51).  
SecA2 is an accessory SecA that is required for exporting a small subset of proteins out 
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of the cytoplasm.  SecA1, as the housekeeping SecA, is essential and functions in the 
general Sec pathway that is used for the majority of protein export that occurs in 
mycobacteria.   
The M. tuberculosis SecA2 system is important for virulence (6, 33). A ΔsecA2 
mutant of M. tuberculosis is attenuated for growth in macrophages and in a mouse model 
of infection.  A possible explanation for the function of the M. tuberculosis SecA2 system 
in pathogenesis might be to modulate host innate immune responses.  Macrophages 
infected with the ΔsecA2 mutant produce higher levels of the proinflammatory cytokines 
TNF-α and IL-6 and increased levels of reactive nitrogen intermediates (RNI).  These 
immunomodulatory factors have roles in controlling M. tuberculosis during host infection 
(19, 34, 38) and they are induced by M. tuberculosis through MyD88-dependent 
signaling pathways (Reviewed in (29)).  Macrophages infected with the ΔsecA2 mutant 
also exhibit higher levels of apoptosis, which is attributed to defective SodA secretion by 
the ΔsecA2 mutant (25).  
Here we studied the ΔsecA2 mutant to take a closer look at the role of SecA2 during 
M. tuberculosis growth in macrophages. We examined the role of apoptosis and increased 
MyD88-dependent inflammatory responses in controlling growth of the ΔsecA2 mutant in 
macrophages.   While these macrophage responses did not appear to explain the role of 
SecA2 in promoting intracellular growth, we did discover an important role for SecA2 in 
blocking phagosome maturation.  We go on to show that SecA2 dependent phagosome 
maturation arrest is required for the growth of M. tuberculosis in macrophages.  
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3.2- Results 
Increased apoptosis does not account for the intracellular growth defect of the M. 
tuberculosis ΔsecA2 mutant.  
 
The ability of M. tuberculosis to inhibit host cell apoptosis could be important for 
intracellular growth of the bacillus (41, 44).  The ΔsecA2 mutant has a proapoptotic 
phenotype, which has been attributed to defective SodA secretion (25). Given this 
phenotype of the ΔsecA2 mutant, we set out to test if increased apoptosis accounts for the 
growth defect of the mutant in macrophages.  To test this possibility we took advantage 
of a plasmid expressing an extra copy of SodA, termed αSodA.  Unlike the endogenous 
M. tuberculosis SodA that lacks an obvious signal sequence for export, αSodA has a Sec 
signal sequence fused to the N-terminus of the enzyme (25).  When αSodA is expressed 
by the ΔsecA2 mutant (ΔsecA2-αsodA) it restores the ability of the ΔsecA2 mutant to 
release SodA activity into culture media and it reverses the proapoptotic phenotype of the 
mutant (25).  It is worthwhile to mention that the details of αSodA release, particularly 
whether it is secreted by the Sec pathway, remain to be worked out.  Nonetheless, 
because αSodA suppresses the propapoptotic phenotype of the ΔsecA2 mutant, we could 
test the ΔsecA2-αsodA strain for growth in murine bone marrow-derived macrophages as 
a way to determine if altered apoptosis is responsible for the intracellular growth 
phenotype of the ΔsecA2 mutant.  In these experiments, both the ΔsecA2 mutant and the 
ΔsecA2-αsodA strain failed to grow in macrophages while the parental H37Rv strain and 
the complemented ΔsecA2 mutant strain grew approximately 10 fold over 5 days (Figure 
3-1A).  These results demonstrated that the ΔsecA2 mutant remains defective for 
intracellular growth even if the enhanced apoptosis phenotype is suppressed.   
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 We similarly tested the role of apoptosis in the attenuated phenotype of the 
ΔsecA2 mutant in mice.  C57BL/6 mice were infected via the aerosol route with the 
ΔsecA2-αsodA strain and in vivo growth and persistence of this strain was compared to 
that seen with murine infection with the ΔsecA2 mutant and H37Rv.  Here too, the 
attenuated phenotype of the secA2 mutant was not suppressed by αSodA expression. In 
fact, in mice αSodA expression by the ΔsecA2 mutant actually exacerbated the in vivo 
growth defect (Figure 3-1B).  Taken together, these results indicated that increased 
apoptosis and the defect in SodA secretion are, at least on their own, unable to explain the 
attenuated phenotypes of the ΔsecA2 mutant in macrophages or mice.  Thus, there must 
exist another role for the SecA2 system in M. tuberculosis virulence.   
  
The ΔsecA2 mutant resides in acidified phagosomes. 
 
The ability of M. tuberculosis to interfere with phagosome maturation is another 
property of the bacillus proposed to be important to intracellular growth (47, 52, 66).  
Because secreted and surface localized proteins of M. tuberculosis are good candidates 
for being involved in phagosome maturation arrest, we tested the potential for the SecA2 
export system to influence phagosome maturation.  Murine bone marrow-derived 
macrophages were infected with H37Rv, the ΔsecA2 mutant or complemented strain and 
we scored the bacilli for co-localization with markers of phagosome maturation using 
widefield fluorescence microscopy. 
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Figure 3-1. Reversal of the ΔsecA2 mutant apoptosis phenotype does 
not rescue growth in macrophages or mice. A. Non-activated bone 
marrow-derived macrophages (BMDM) were infected with H37Rv, ΔsecA2, 
ΔsecA2 + psecA2 (complemented strain), or ΔsecA2 + α-sodA strains of M. 
tuberculosis and intracellular replication monitored as described. The data 
shown is plotted in linear scale and is representative of two experiments, 
points represent means of triplicate wells and error bars represent SD, * p< 
0.05 by student’s t test. B. Lung and spleen burden in mice infected through 
aerosol route at an initial dose of ~200 cfu/lung with H37Rv, ΔsecA2, or the 
ΔsecA2 + α-sodA strain. We determined cfu counts by plating lung or spleen 
homogenates at various time points for viable bacteria. Data shown is a single 
experiment, bars represent mean organ burden from four mice and error bars 
represent SD, * p< 0.05 by Student’s t test. 
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 To detect bacilli in macrophages we took advantage of the recently described 
autofluorescence of mycobacteria (45).  Using scanning spectrophotometry, we first 
experimentally determined the optimal peak excitation and emission wavelengths (415nm 
and 470nm, respectively) for autofluorescence of paraformaldehyde fixed M. 
tuberculosis.  These wavelengths can be detected by fluorescence microscopy using a 
standard CFP filter set.  To validate the use of autofluorescence to localize M. 
tuberculosis, we evaluated a series of GFP expressing wild-type and mutant M. 
tuberculosis strains and compared GFP and autofluorescence signals. GFP expression is 
commonly used to visualize M. tuberculosis in macrophages (65, 70).  All GFP positive 
cells were visible by autofluorescence (Figure 3-2); this was also true with bacilli in 
macrophages (data not shown).   
It is well-established that in non-activated macrophages, wild-type M. tuberculosis is 
primarily found in non-acidified phagosomes (46, 52, 54, 66).  To assess acidification of 
phagosomes containing the ΔsecA2 mutant we used LysoTracker Red (Invitrogen), which 
is an acidotropic dye frequently employed in studies of phagosome maturation (66, 70).  
By measuring co-localization of LysoTracker and M. tuberculosis autofluorescence 
signals, the parental H37Rv strain was found to largely avoid phagosome acidification, as 
reported previously (46, 54).  In comparison, we detected the ΔsecA2 mutant in a 
significantly higher percentage of acidified phagosomes and this phenotype was reversed 
in the complemented strain (Figure 3-3A).  
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Figure 3-2. M. tuberculosis autofluorescence can be used to identify 
bacilli by microscopy. M. tuberculosis strains used in this study carrying a 
GFP expression plasmid were grown to mid-log phase and fixed in 4% 
paraformaldehyde in PBS. Fixed bacteria were loaded into the well of a 
chambered cover slip and visualized in the CFP and GFP channels on a 
widefield fluorescence microscope. Autofluorescence in the CFP channel is 
compared to GFP fluorescence in strains expressing GFP from a plasmid. The 
overlap is demonstrated in the merged images where yellow color indicates a 
positive correlation. 
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Experiments with GFP expressing versions of these strains, where GFP was used to 
localize the bacilli, gave the same results as obtained by scoring autofluorescence (data 
not shown).  The ΔsecA2 mutant’s association with acidified phagosomes was evident as 
early as one-hour post infection (Figure 3-3A). 
 We compared the phagosome acidification phenotype of the ΔsecA2 mutant to 
that of a mutant defective for ESX-1 secretion (ΔeccD1).   As reported previously for esx-
1 mutants, the ΔeccD1 mutant exhibited a higher association with LysoTracker positive 
phagosomes in comparison to H37Rv (Figure 3-3B) (8).  The esx-1 mutant phenotype 
was repeatedly less dramatic than the ΔsecA2 mutant phenotype. This finding that both a 
ΔsecA2 mutant and esx-1 mutants are associated with increased phagosome acidification 
joins a list of other similarities reported for these mutants (20, 24, 28, 33, 37, 55). This 
raised the possibility that the SecA2 and ESX-1 systems might work together to export 
critical effector proteins of phagosome maturation.  To test this possibility, we assayed 
phagosome acidification of a M. bovis BCG ΔsecA2 mutant.  BCG lacks ESX-1 because 
the chromosomal locus encoding the system is deleted (49).  As was the case in M. 
tuberculosis, a BCG ΔsecA2 mutant exhibited a higher association with LysoTracker 
positive phagosomes than the parental BCG Pasteur strain (Figure 3-3C). This result 
indicated that the role(s) of the SecA2 system in arresting phagosome maturation is 
independent of the ESX-1 system. 
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Figure 3-3. Compared to H37Rv, the ΔsecA2 mutant is enriched in 
LysoTracker positive phagosomes. Non-activated BMDMs were infected 
with A. H37Rv, the ΔsecA2 mutant or complemented strain, B. H37Rv, 
ΔsecA2, or ΔeccD1, or C. BCG Pasteur or a ΔsecA2 mutant on the BCG 
Pasteur background. At indicated times the slides were stained with 
LysoTracker and scored for LysoTracker positive phagosomes as 
described above. Also shown, sample microscopy images from the 
experiment in panel A (LT = LysoTracker). Shown are representative 
experiments of at least three independent experiments. Bars represent 
mean percentage of bacteria-containing phagosomes that stain positive for 
LysoTracker; error bars represent SD of three replicate wells, each well 
having >100 phagosomes scored. *p≤0.05 by Student’s t test when 
compared to WT. 
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The localization of the ΔsecA2 mutant to acidified phagosomes is not a general 
property of M. tuberculosis mutants with intracellular growth defects.  
 
Increased association of the ΔsecA2 mutant with acidified phagosomes could 
result from an inability to carry out a role in blocking phagosome acidification, such as 
failure to secrete an inhibitor of phagosome maturation.  Alternatively, the ΔsecA2 
mutant could be delivered to acidified phagosomes as a secondary consequence of a 
failure to grow in macrophages.  In considering the second possibility, we asked whether 
unrelated mutants that fail to replicate in macrophages are also found in acidified 
phagosomes.  For this reason, we investigated the acidification status of phagosomes 
containing the M. tuberculosis leucine auxotroph (ΔleuD).  The ΔleuD mutant is a 
metabolic mutant that fails to synthesize leucine and fails to grow in macrophages (26).   
Unlike the ΔsecA2 mutant, the ΔleuD mutant resembled H37Rv in its association with 
non-acidified phagosomes, even 72 hours post infection, indicating that this mutant 
maintained the ability to block phagosome acidification (Figure 3-4A). We additionally 
screened for phagosome acidification defects of M. tuberculosis transposon mutants 
recently identified as being defective for intracellular growth (40). Transposon mutants in 
rv0199, mce1A, or mce2F also resembled H37Rv in ability to block phagosome 
acidification (Figure 3-4B). These data indicated that localization to acidified 
phagosomes, as assessed by LysoTracker staining, is not true for all M. tuberculosis 
mutants that are defective for intracellular growth.  Along with the finding that the 
ΔsecA2 mutant is observed in acidified phagosomes quickly (1hr) post-infection (Figure 
3-3, 3-4A), these results argue for a specific role for the SecA2 system in blocking 
phagosome acidification. 
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Figure 3-4. Not all M. tuberculosis mutants with intracellular growth 
defects are enriched in LysoTracker positive phagosomes. Non-
activated BMDMs were infected with A. H37Rv, ΔsecA2 or ΔleuD B. 
H37Rv, ΔsecA2 , mce1A::tn, mce2F::tn or rv0199::tn. At indicated times 
the slides were stained with LysoTracker and scored for LysoTracker 
positive phagosomes as described above. Shown are representative 
experiments of at least three independent experiments. Bars represent 
mean percentage of bacteria-containing phagosomes that stain positive for 
LysoTracker; error bars represent SD of three replicate wells. *p≤0.05 by 
student’s t test when compared to H37Rv. 
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Other markers of maturation are associated with phagosomes containing the 
ΔsecA2 mutant.  
 
Vacuolar ATPase (V-ATPase) is a molecular motor that drives a proton gradient 
across membranes.  V-ATPases are used by eukaryotic cells to acidify vacuoles. It is 
reported that M. tuberculosis phagosomes do not acidify, at least in part, because V-
ATPase is either prevented from associating with or quickly degraded from the 
phagosome (54, 57). We wanted to determine if the higher association of the ΔsecA2 
mutant with acidified phagosomes correlates with higher V-ATPase association.  
Macrophages infected with the ΔsecA2 mutant, H37Rv, or complemented strain were 
immunostained with antibodies to murine V-ATPase and co-localization was scored.   
We found a significantly higher percentage of phagosomes containing the ΔsecA2 mutant 
stained positive for V-ATPase than phagosomes containing H37Rv or the complemented 
strain (Figure 3-5A).  The increased association with V-ATPase positive phagosomes 
seen with the ΔsecA2 mutant was equivalent to that seen with the ΔeccD1 mutant. 
Phagosome acidification is a relatively early step in phagosome maturation (17).  To 
further characterize the ΔsecA2 mutant containing phagosome for evidence of 
phagosome/lysosome fusion, we immunostained infected macrophages for markers of 
late-endosomal/lysosomal fusion (CD63 and Rab7). Wild-type M. tuberculosis is 
reported to prevent phagosomes from maturing to a CD63 and Rab7 positive state (12, 
31, 65). In comparison to phagosomes containing H37Rv or the complemented strain, a 
higher percentage of ΔsecA2 mutant-containing phagosomes stained positive for CD63 
and Rab7.  Once again, the phenotype of the ΔsecA2 mutant was similar to that of the 
ΔeccD1 mutant (Figure 3-5B, C).
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Figure 3-5. Compared to H37Rv, the ΔsecA2 mutant is enriched in 
phagosomes positive for late endocytic/lysosomal markers. Non-
activated BMDMs were infected with H37Rv, ΔsecA2, complemented ΔsecA2, 
or the ΔeccD1 mutant for 24 hours and immunofluorescently stained for 
markers of phagosome maturation as described above. A. V-ATPase, B. 
CD63 and C. Rab7. A representative experiment of three independent 
experiments is shown. Bars represent mean percentage of bacteria-containing 
phagosomes that stain positive for marker; error bars represent SD of three 
replicate wells, each well having >100 phagosomes scored. *p≤0.05 by 
Student’s t test compared to H37Rv. Representative microscopy images for 
each set of markers are shown. 
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Together, these results indicated that phagosomes containing the ΔsecA2 mutant have a 
higher association with V-ATPase, which could account for the observed higher percent 
acidification detected with LysoTracker.  The ΔsecA2 mutant-containing phagosomes 
also have a higher association with markers indicative of late endosomal/lysosomal 
fusion indicating a defect in later stages of phagosome maturation arrest as well (Figure 
3-5B, C).  
 
MyD88 signaling is not responsible for the altered phagosome maturation or 
intracellular growth phenotypes of the ΔsecA2 mutant.  
 
We previously reported that during macrophage infection the ΔsecA2 mutant 
induces higher levels of TNF-α, IL-6, and RNI in comparison to infection with H37Rv 
(33). All three of these immunomodulatory molecules are induced by M. tuberculosis 
through TLR and MyD88 pathways (7, 32, 50).  Because TLR and MyD88 signaling are 
implicated in driving phagosome maturation events (4, 71), we considered the possibility 
that increased signaling through these pathways was responsible for the trafficking 
defects of the ΔsecA2 mutant.  To address the significance of MyD88-dependent 
responses to ΔsecA2 mutant phenotypes in macrophages, we tested the ΔsecA2 mutant 
and H37Rv in parallel infections of primary MyD88 deficient macrophages (MyD88-/-) 
and C57BL/6 macrophages. As reported by others, MyD88-/- macrophages showed a 
significant decrease in level of secreted TNF-α and IL-6 in response to M. tuberculosis 
infection (22, 60). The TNF-α and IL-6 levels from H37Rv or ΔsecA2 mutant infected 
MyD88-/- macrophages were the same and equivalent to the levels produced by 
uninfected macrophages (data not shown).   
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 As in C57BL/6 macrophages, ΔsecA2 mutant-containing phagosomes in MyD88-/- 
macrophages stained positive more than H37Rv-containing phagosomes with 
LysoTracker, V-ATPase, CD63, and Rab7. The difference between the ΔsecA2 mutant 
and H37Rv phagosomes in MyD88-/- macrophages was equivalent to that seen in 
C57BL/6 macrophages (Figure 3-6A).  We also tested the ΔsecA2 mutant for growth in 
MyD88-/- macrophages.  In MyD88-/- macrophages the ΔsecA2 mutant was as defective 
for intracellular growth as is seen in C57BL/6 macrophages (Figure 3-6B).  Aerosol 
infection of MyD88-/- mice with the secA2 mutant also showed that the absence of 
MyD88-/- had no effect on the in vivo growth defect of the ΔsecA2 mutant in mice at early 
time points (data not shown).  Thus, the explanation for the intracellular trafficking and 
growth defects of the ΔsecA2 mutant appears to be unrelated to MyD88-signaling.  
 
Phagosome acidification is necessary for the intracellular growth phenotype of the 
ΔsecA2 mutant.  
 
There are other M. tuberculosis mutants reported to have defects in blocking 
phagosome maturation (8, 31, 36, 46, 56, 67). In the majority of cases, phagosome 
maturation arrest mutants are also defective for intracellular growth (for example, esx-1 
mutants).  However, with the exception of a few studies (23, 30, 68), the causal 
relationship between localization to a more mature phagosome and inhibition of growth 
remains largely untested.  With the goal of determining if the phagosome maturation 
arrest defect of the ΔsecA2 mutant is responsible for the growth defect in macrophages, 
we used macrolide antibiotic V-ATPase inhibitors (bafilomycin A1 and concanamycin A) 
(15) to block acidification of ΔsecA2 mutant containing phagosomes and asked if this 
treatment rescued growth of the mutant.  
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Figure 3-6. MyD88 has no effect on ΔsecA2 mutant phagosome 
trafficking or intracellular growth. A. Non-activated BMDMs derived from 
C57BL/6 or MyD88-/- mice were infected with H37Rv or the ΔsecA2 mutant. 
At 24 hours post infection the slides were stained with LysoTracker or 
antibodies to CD63, Rab7 or V-ATPase and scored for marker positive 
bacteria-containing phagosomes as described above. Bars represent mean 
percentage of bacteria-containing phagosomes that stain positive for 
marker; error bars represent SD of three replicate wells. There are no 
significant differences between C57BL/6 and MyD88-/- macrophages when 
infected with the ΔsecA2 mutant. B. Non-activated BMDMs from C57BL/6 
(open symbols) or MyD88-/- (closed symbols) mice were infected with 
H37Rv or the ΔsecA2 mutant and intracellular replication monitored as 
described. The data shown is plotted in linear scale and is a representative 
experiment of three, points are mean of three replicate wells, error bars 
represent SD. *p≤0.05 by student’s t test compared to H37Rv.  
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To minimize pleiotropic effects of the inhibitors on macrophages, we experimentally 
determined a minimum concentration of each inhibitor (10nM Bafilomycin A1 and 5nM 
Concanamycin A) required to prevent acidification of the ΔsecA2 mutant containing 
phagosomes, as measured by LysoTracker co-localization at 24 hours post infection 
(Figure 3-7A). These concentrations had no detectable effect on macrophage viability 
over the course of a five-day infection (data not shown).   In contrast to untreated 
macrophages, the ΔsecA2 mutant and H37Rv grew equally well in macrophages treated 
with 10nM bafilomycin A1 (Figure 3-7B).  While bafilomycin treatment increased 
growth of both H37Rv and the ΔsecA2 mutant in macrophages over 5 days (Figure 3-7B), 
the effect of bafilomycin was small and not significant for H37Rv but significantly 
greater for the ΔsecA2 mutant (Figure 3-7C).  
To establish the specificity of this rescue, we also tested the effect of bafilomycin 
on intracellular growth of the ΔleuD mutant, which is not localized to acidified 
phagosomes (Figure 3-4A).  Bafilomycin A1 treatment of the ΔleuD mutant did not 
rescue growth to the level of H37Rv in bafilomycin treated macrophages (Figure 3-7B, 
C).  Experiments with 5nM concanamycin A showed the same effect of rescuing the 
intracellular growth defect of the ΔsecA2 mutant.  Growth of the ΔsecA2 mutant was 
equivalent to that of H37Rv in concanamycin A treated macrophages (Figure 3-7D, E).  
Together, these results indicated the importance of phagosome acidification for inhibiting 
intracellular growth of the ΔsecA2 mutant.  Our data further argues that phagosome 
maturation can result in inhibition of M. tuberculosis intracellular replication. 
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Figure 3-7. Growth of the ΔsecA2 mutant is inhibited by phagosome 
acidification. A. LysoTracker positive phagosomes in BMDMs infected with 
H37Rv or ΔsecA2 mutant and treated with bafilomycin A1 or concanamycin A. 
Shown are the lowest inhibitor concentrations that bring ΔsecA2 LysoTracker 
positive phagosomes to H37Rv levels, ND = not determined. B. Non-activated 
BMDMs treated with bafilomycin A1 or vehicle control (DMSO) were infected 
with H37Rv, ΔsecA2 or ΔleuD and intracellular replication monitored as 
described. Shown is a representative experiment of four independent 
experiments. Bars represent mean fold growth over five days of three replicate 
wells +SD. * p<0.05 by Student’s t test. C. Data from the above experiment (7B) 
combined with three independent experiments to show the fold effect of 
bafilomycin A1 on intracellular growth compared to untreated macrophages. 
Bars represent mean fold effect of bafilomycin A1 in four individual experiments 
+SEM, *p<0.05 by Student’s t test compared to H37Rv. D and E, as in B and C, 
with concanamycin A or DMSO. D. Shown is a representative experiment of 
three experiments. E. Bars represent mean fold effect of concanamycin in three 
experiments +SEM, *p<0.05 by Student’s t test compared to H37Rv.  
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3.3- Discussion 
The function of the accessory SecA2 export system in promoting growth in 
macrophages has remained elusive.  Previously, we tested if the role of the SecA2 system 
is to protect against the oxidative or nitrosative stresses produced by macrophages during 
infection (33).   These past studies showed that even in the absence of these reactive 
radical stresses the ΔsecA2 mutant remains attenuated in macrophages.  Thus, the SecA2 
system must have other roles in promoting M. tuberculosis growth in macrophages.  In 
this study, we considered alternate explanations.  We tested if the inhibition of 
macrophage apoptosis mediated by the SecA2 system is what promotes M. tuberculosis 
growth in macrophages.  Our results from testing the ΔsecA2-αsodA strain do not support 
this possibility.  While expression of the αsodA construct in the ΔsecA2 mutant 
suppresses the proapoptotic phenotype, the strain remained defective for intracellular 
growth (Figure 3-1A).  It is worthwhile to note that our results do not rule out other 
important roles of the apoptosis phenotype of the M. tuberculosis ΔsecA2 mutant as 
reported elsewhere, such as enabling enhanced adaptive immune responses and increased 
protective immunity in vaccination studies (25). 
  In considering other explanations for the function of the SecA2 system in 
macrophages we tested the ΔsecA2 mutant for the ability to arrest phagosome maturation.  
Our results showed the ΔsecA2 mutant to be defective in phagosome maturation arrest, as 
the mutant was more readily trafficked to a more mature phagosome than the parental 
H37Rv strain.  This defect was evident quickly after infection (1hr), and not exhibited by 
other mutants with intracellular growth defects even at later times post-infection (72 hr).   
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Additionally, we showed that treating macrophages with inhibitors of the V-ATPase 
prevented acidification of phagosomes and rescued the intracellular growth defect of the 
ΔsecA2 mutant.  From these results, we conclude that the accessory SecA2 export system 
has a specific role in blocking phagosome acidification and that the intracellular growth 
defect of the ΔsecA2 mutant is directly related to its defect in blocking phagosome 
maturation.  
 Correlations exist between phagosome maturation and M. tuberculosis growth 
arrest (8, 35, 46, 56), and the ability of M. tuberculosis to arrest phagosome maturation is 
generally assumed to be critical for pathogenesis and for growth in macrophages.  Yet, 
there are a few examples of mutants that are able to grow even though they reside in 
more mature phagosomes (8, 36, 46), which raises the possibility that phagosome 
maturation arrest is not essential for M. tuberculosis intracellular growth.  Our results 
showing both bafilomycin A1 and concanamycin A rescue the ΔsecA2 mutant 
intracellular growth defect are significant in demonstrating the ability of V-ATPase 
mediated phagosome acidification to control M. tuberculosis growth. This argues that the 
avoidance of phagosome acidification by virulent M. tuberculosis is necessary for 
intracellular growth.  In addition to rescuing growth of the ΔsecA2 mutant, bafilomycin 
and concanamycin treatment also modestly increased the replication efficiency of 
H37Rv.  This effect on H37Rv is most likely due to the inhibitors further decreasing the 
percentage of H37Rv associated with acidified phagosomes (Figure 3-7).  A similar result 
was reported by Welin et al. with H37Rv infection of bafilomycin treated human 
monocyte derived macrophages (68).   
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How might phagosome acidification control M. tuberculosis infection? Although 
low pH can render media components toxic to M. tuberculosis, which complicates 
assessing growth at acid pH (61), M. tuberculosis replication is reported to be sensitive to 
low pH (48).  Therefore, it is possible that phagosome acidification is directly responsible 
for the growth inhibition of the ΔsecA2 mutant in macrophages.  Alternatively, the acidic 
environment may be activating the pH sensitive lysosomal hydrolases (52) and thereby 
limiting replication.  A final possibility is that the acidification of the phagosome is 
driving downstream fusion events that produce the growth restricting environment (11, 
58).  
 Because metabolically inactive bacteria are more readily found in acidified 
phagosomes (35), it has been suggested that mutants impaired in any aspect of growth or 
metabolic activity may be found in mature phagosomes as a secondary consequence of 
those defects, as opposed to a direct effect on phagosome maturation (47).  Because we 
observed the ΔsecA2 mutant in more mature phagosomes at early times post-infection 
and because V-ATPase inhibitors rescued the growth defect, we think it unlikely that 
general growth or metabolic defects account for the ΔsecA2 mutant phenotype.  
Moreover, we tested the leucine auxotroph (ΔleuD) of M. tuberculosis as an example of a 
mutant severely compromised in metabolic activity.  The ΔleuD mutant requires leucine 
supplementation to grow in liquid media and the mutant does not grow in macrophages, 
presumably due to a failure to acquire leucine from the intracellular environment (26).  
Somewhat surprisingly, the ΔleuD mutant behaved like H37Rv and maintained its ability 
to avoid phagosome acidification, even at the latest (72hr) time point.  Although the 
precise level of metabolic activity of the ΔleuD mutant in macrophages is not known, this 
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result suggests that general growth or metabolic defects do not necessarily lead to a 
breakdown in phagosome maturation arrest. 
 What is currently known about the process of phagosome maturation arrest by M. 
tuberculosis suggests it is a complex process involving several effectors. It seems likely 
that M. tuberculosis has multiple effectors targeting a minimum of two parallel pathways 
that are critical to phagosome maturation: PI(3)P accumulation/signaling and Rab7 
accumulation/activation (10, 47, 62). The phagosome maturation defect of the ΔsecA2 
mutant may be due to a defect in the secretion of such effectors. Several M. tuberculosis 
secreted proteins (i.e. LpdC, NdkA, PknG, PtpA, and SapM) affect phagosome 
maturation or pathways thought to be critical for phagosome maturation (3, 14, 59, 63, 
67).  This list of possible effectors is likely incomplete, however, as mutant screens to 
find effectors of phagosome maturation suggest the existence of a much broader set of 
proteins involved in arresting phagosome maturation (8, 36, 46, 56).  There are also M. 
tuberculosis surface lipids (lipoarabinomannan, phosphotidylinositol mannoside, and 
tetra-acylated sulfoglycolipid) (8, 21, 64) reported to affect phagosome maturation. The 
SecA2 system could be involved in surface lipid production or localization by exporting 
lipid synthesis or export machinery.   
 An alternate way that the SecA2 system could promote phagosome maturation 
arrest would be to limit macrophage responses that drive downstream phagosome 
maturation events.  With this idea in mind we considered the possibility that the more 
robust MyD88-dependent responses elicited by the ΔsecA2 mutant (33) might be 
responsible for the altered trafficking of the ΔsecA2 mutant.  Although our experiments 
with MyD88-/- macrophages revealed this not to be the case, it only excludes altered 
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phagosome trafficking as a downstream event of MyD88 signaling.  Macrophages can 
detect M. tuberculosis through MyD88-independent intracellular receptors such as the 
NLR family of receptors and the inflammasome, which could also drive phagosome 
maturation (39). 
The microscopy experiments performed in the course of this work are the first to 
take advantage of the autofluorescence of mycobacteria to co-localize intracellular bacilli 
with phagosomal markers.  Previously, either exogenous fluorescent proteins (GFP, RFP) 
or fluorescent dyes have been used to track mycobacteria in similar experiments (54, 56). 
While GFP fluorescence has the advantage over autofluorescence of being brighter and 
longer-lasting, it has the disadvantage of requiring the construction of strains that express 
exogenous genetic elements and there is the potential for GFP expression itself to 
influence virulence (42).  The use of dyes to surface label the bacilli have a similar 
disadvantage in introducing an experimental variable that could possibly alter the course 
of infection (54).   
The work presented here not only provides a better understanding of how SecA2 
promotes M. tuberculosis growth in macrophages, but it also demonstrates the 
importance of phagosome maturation arrest for M. tuberculosis.  It seems likely that M. 
tuberculosis has multiple effectors of phagosome maturation arrest.  As is the case in the 
Type IV secretion system of Legionella pneumophila, this may mean there is substantial 
effector redundancy (43).  The phagosome maturation phenotype of the ΔsecA2 mutant 
indicates there is a single critical effector or multiple effectors that depend on the SecA2 
export pathway. Future studies will seek to identify such SecA2-dependent effectors of 
phagosome maturation arrest.  
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3.4- Materials and Methods 
Bacterial strains and growth conditions 
 
 In this study we used Mycobacterium tuberculosis strains listed in Table 1. M. 
tuberculosis strains were cultured in liquid Middlebrook 7H9 media or solid 7H10 
supplemented with 0.05% Tween 80, 0.5% glycerol, 1× albumin dextrose saline (ADS), 
and appropriate drugs kanamycin (20µg/ml) or hygromycin (50µg/ml).  For plating organ 
homogenates from murine infections, cyclohexamide (10µg/ml) was incorporated into 
7H10 agar to inhibit fungal growth.  For experiments with the ΔleuD mutant all media 
was additionally supplemented with 50µg/ml L-leucine.  
 
Mutant construction  
 
The M. tuberculosis ΔeccD1 null mutant was constructed by specialized 
transduction using an allelic exchange construct delivered by the temperature-sensitive 
mycobacteriophage phAE159, as described previously (5).   The allelic exchange 
construct was constructed by amplifying flanking regions of eccD1 (rv3877) by PCR 
from M. tuberculosis genomic DNA.  An 833 bp upstream flanking sequence (ending at 
the second codon of eccD1) and an 821 bp downstream flanking sequence (starting at the 
fifth codon from the stop) were amplified and individually cloned into the pCR 2.1 
cloning vector (Invitrogen).  These flanking sequences were then sequentially cloned into 
pJSC284 to create plasmid pKO-3877, which has the hygromycin (hyg) cassette marking 
the deletion and positioned between the two flanking sequences.  PacI digested pKO-
3877 was then ligated to PacI cut phAE159 and in vitro packaged (Stratagene) into 
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lambda phage particles that were recovered by transduction in E. coli.  The resulting 
recombinant mycobacteriophage was then used to transduce H37Rv at the non-
permissive temperature of 39°C for 4 hours.  Transduced cells were pelleted, resuspended 
in 7H9 media with 0.1% Tween 80, and plated on 7H10 agar with hygromycin. 
Hygromycin-resistant colonies obtained at 3 weeks were screened for allelic exchange by 
Southern blotting to confirm deletion of eccD1. 
The ΔsecA2 null mutant in BCG Pasteur was constructed as previously reported 
for BCG Tice and H37Rv strains using a two-step allelic exchange method (6, 53).  
 
Antibodies and reagents 
 
 Antibodies to mammalian markers (CD63, Rab7 and V-ATPase B1/B2) and 
fluorophore conjugated secondary antibodies were acquired from Santa Cruz 
Biotechnology. The α-SodA construct (pMV3α-sod) was a kind gift of Dr. William 
Jacobs Jr. (Albert Einstein College of Medicine, Bronx NY) (25). Bafilomycin A1 
(Sigma) and concanamycin A (Santa Cruz) were stocked at 1000× in DMSO. 
 
Animals 
 
 C57BL/6 mice acquired from Charles River Labs were used in aerosol infections 
and for bone marrow-derived macrophages. MyD88-/- mice on the C57BL/6 background 
(1) were acquired from Dr. Shizuo Akira (WPI Immunology Frontier Research Center, 
Research Institute for Microbial Diseases, Osaka University, Osaka Japan). All mice 
were housed in sterile caging and provided sterile food and water. All animal protocols 
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were followed strictly as approved by the UNC Institutional Animal Care and Use 
Committee (IACUC). 
 
Aerosol infection and necropsy 
 
 Aerosol infection of mice was performed using a Madison aerosol chamber. 
Briefly, mice were exposed to a whole body aerosol generated from M. tuberculosis that 
was grown to log-phase and washed once and resuspended in PBS containing 0.05% 
Tween 80 at a concentration of 1.2 × 107 colony forming units (cfu)/ml. The mice were 
exposed to aerosols for 15 minutes with a 20-minute purge to clear the chamber resulting 
in an approximate dose of 200 cfu/lung. At various time points mice were euthanized, 
their lungs and spleens homogenized and plated for cfu on 7H10 agar.  
 
Macrophage infections 
 
 Bone marrow-derived macrophages were made as follows.  Mice were euthanized 
by CO2 asphyxiation and cervical dislocation. Femurs were removed and bone marrow 
flushed out with supplemented Dulbecco modified Eagle medium (DMEM; Sigma). 
DMEM was supplemented with 10% fetal bovine serum (FBS; Gibco), 2mM L-
glutamine, and 1× nonessential amino acids (complete DMEM). Bone marrow cells were 
washed once and resuspended and plated in complete DMEM containing 20% L-929 cell 
conditioned media (LCM). After six days at 37°C, 5% CO2, the cells were lifted off the 
plates using cold PBS EDTA 5mM and scraping. The cells were then washed twice and 
resuspended at a concentration of 1 × 106 macrophages/ml in complete DMEM 
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containing 10% LCM. Macrophages were then seeded at 2 × 105 macrophages/well in 
eight-well chambered slide or chambered cover slips for microscopy experiments. 
 After resting 24-48 hours the macrophages were infected with M. tuberculosis 
culture grown to log-phase, and washed once with PBS containing 0.05% Tween 80 and 
diluted in warm complete DMEM. Macrophages were infected at an MOI of 1.0 for 
microscopy or 0.2 for intracellular growth assays. After a four-hour incubation at 37°C 
for bacterial uptake, infected macrophages were washed three times with pre-warmed 
complete DMEM. The zero hour time point of these experiments represents the time after 
the washes were complete. For kinetic growth assays macrophages were lysed at various 
time points and lysates were plated for cfu.  For microscopy, cover slips were taken at 
various time points and fixed for at least one hour in 4% paraformaldehyde (PFA) in PBS 
pH 7.4.  For experiments using bafilomycin A1 (Sigma) or concanamycin A (Santa Cruz) 
the inhibitors or equivalent vehicle control were added to the macrophages 30 minutes 
prior to infection. Inhibitors were maintained throughout the five-day infection. 
 
Macrophage staining and microscopy 
 
 To stain with LysoTracker, media was replaced with prewarmed DMEM +100nM 
LysoTracker Red DND99 (Invitrogen) and returned to 37°C 5% CO2 for one hour.  For 
immunofluorescence, media was aspirated from the wells at the endpoint of infection and 
cover slips were submerged in 4% PFA for at least one hour.  To stain for 
immunofluorescence, fixed macrophages in chambered cover slips were submerged in 
PBS to remove residual PFA.  Cells were then permeabilized with 0.1% Triton-X 100 in 
PBS for 5 minutes at room temperature, washed in PBS and blocked in PBS + 10% 
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serum from the same source as the secondary antibody. Primary antibodies were used at a 
1:100 dilution in PBS + 3% serum and incubated overnight at 4°C. After extensive 
washing in PBS, secondary antibodies conjugated to fluorophores were used at 1:100 in 
PBS + 3% serum and incubated at room temperature for one hour. After secondary 
antibodies were washed away, Fluormount-G (Southern Biotech) was added to each well. 
As an important control, we showed that normal rabbit IgG and secondary antibody alone 
did not stain M. tuberculosis containing phagosomes. 
 Widefield fluorescence microscopy was performed using an Olympus IX-81 
controlled by the Volocity software package. All images were taken using a 40× oil-
immersion objective. A minimum of five fields per well was captured and bacteria were 
scored for phagosomal markers, amounting to a minimum of 100 bacteria-containing 
phagosomes scored per well. For each experimental group three replicate wells were 
scored per experiment. 
 Mycobacterial autofluorescence was visualized using a CFP filter cube (Semroc) 
with an excitation band of 426-450nm and emission band of 467-600nm.  A 3% 
transmission, neutral density filter was used and minimal time was spent focusing in the 
CFP channel to protect the autofluorescence from photobleaching. 
 
Table 3-1. Mycobacteria strains used 
Strain Description Reference 
M. tuberculosis   
H37Rv Wild-type Trudeau Institute 
mc23112 H37Rv ΔsecA2 (6) 
MBTB74 H37Rv ΔsecA2, attB::secA2 This study 
MBTB109 H37Rv ΔsecA2, attB::αsodA (25), This study 
mc23032 H37Rv ΔleuD (26) 
MBTB3 H37Rv ΔeccD1 This study 
PM638 H37Rv ΔblaC (18) 
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MBTB204 PM638, mce1A::tn (40) 
MBTB156 PM638, mce2F::tn (40) 
MBTB183 PM638, rv0199::tn (40) 
MBTB157 H37Rv, gfp This study 
MBTB158 mc23112, gfp This study 
MBTB159 MBTB74, gfp This study 
MBTB390 mc23032, gfp This study 
M. bovis BCG   
BCG Pasteur Wild-type Staten Serum Institut 
MB544 BCG Pasteur ΔsecA2 This Study 
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CHAPTER IV 
 
 
 
 
TESTING A ROLE FOR THE ACCESSORY SECA2 SYSTEM IN EXPORTING 
MYCOBACTERIUM TUBERCULOSIS EFFECTORS OF PHAGOSOME 
MATURATION1 
 
 
 
 
 
4.1- Introduction 
 Mycobacterium tuberculosis, the causative agent of tuberculosis disease, 
primarily resides in macrophages during infection of a host (21). After being engulfed by 
macrophages through receptor-mediated phagocytosis (12), M. tuberculosis has the 
remarkable ability to survive and grow in the normally hostile environment of 
macrophages. M. tuberculosis manipulates phagosome trafficking to prevent acidification 
and phagosome maturation (19, 20). By preventing the process of phagosome maturation 
it is thought that M. tuberculosis creates an intracellular niche amenable to bacterial 
replication.  
 While it is a well-established fact that M. tuberculosis blocks phagosome 
maturation in macrophages (1, 9, 20, 24), the process by which M. tuberculosis achieves 
this is not yet clear. Through multiple genetic screens and direct tests of potential 
effectors there is an extensive list of genes, proteins and lipids that could play some role 
                                                
1 Authored by: Jonathan Tabb Sullivan, Ellen F. Young, Meghan E. Feltcher, and Miriam 
Braunstein 
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in blocking phagosome maturation(2, 6, 11, 13, 15, 17, 18, 23, 26-28). Interestingly, there 
is minimal overlap of the factors identified by these various approaches. The list of 
potential M. tuberculosis molecules involved in phagosome maturation arrest suggests a 
complex process that probably involves multiple molecules working in tandem. As 
presented in chapter 3, the accessory SecA2 protein export system of M. tuberculosis is 
required for phagosome maturation arrest during macrophage infection (25).  However, 
the role of the SecA2 system in blocking phagosome maturation remains to be defined. 
Because SecA2 is a cytoplasmic protein required for the export of a specific subset of 
proteins (4, 14), we hypothesize that one or more effectors of phagosome maturation are 
proteins exported by the SecA2 system.   
 In this chapter, we assay a set of potential effectors of phagosome maturation 
arrest (2, 7, 11, 26-28) for evidence of export by the SecA2 pathway. More specifically, 
we tested proteins reported to have roles in blocking phagosome maturation (LpdC, 
NdkA, PtpA and SapM) for SecA2 dependent export. As reviewed in chapter 1, these 
putative effectors of phagosome maturation arrest are implicated in diverse roles in 
blocking the process. LpdC is proposed to block phagosome maturation by retaining 
Coronin 1A at the phagosomeal membrane (11). NdkA, is proposed to interfere with GTP 
association with Rab GTPases on the phagosomal membrane, which are required for 
phagosome maturation (26). PtpA is shown to interfere with phagosome-lysosome fusion, 
via association with the V-ATPase and dephosphorylation of the Vps33B component of 
the HOPS complex (29). SapM is proposed to interfere with PI(3)P signaling by 
dephosphorylating PI(3)P at the phagosomal membrane (27).  
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4.2- Results 
LpdC and NdkA are SecA2 independent. 
 
 To determine if specific M. tuberculosis proteins reported to effect phagosome 
maturation are exported in a SecA2 dependent manner, we used western blot analysis to 
compare the amount of proteins secreted into culture media (culture filtrates – CF) by the 
∆secA2 mutant and H37Rv strains of M. tuberculosis.  Concentrated short-term culture 
filtrates were generated in the following manner.  Individual strains were grown to an 
OD600 of ~1 in 7H9 Middlebrook media. The cultures were then washed and transferred 
to Sauton media in triplicate samples at an OD600 of 0.3. The 50 ml Sauton cultures were 
incubated in roller-bottles for 24 hours at 37°C then the cells were pelleted and the 
supernatant collected, filtered to remove cells and concentrated to generate the culture 
filtrate (CF) fraction. The cell pellets from the same cultures were fixed overnight in 10% 
formalin and later used to generate the whole-cell lysate (WCL) fractions. Using 
antibodies raised against an LpdC peptide or full-length M. tuberculosis NdkA we 
detected both LpdC and NdkA as secreted into culture filtrates by M. tuberculosis. As a 
lysis control, CF samples were shown to be devoid of the cytoplasmic SecA1 protein by 
western blot analysis (data not shown). However, for both LpdC and NdkA comparable 
protein levels were observed in culture filtrates from H37Rv and the ∆secA2 mutant 
(Figure 4-1). Thus, the accessory SecA2 system does not appear to be involved in the 
export of these proteins.  
 With the same culture filtrates we also probed for the presence of PtpA using an 
anti-PtpA antibody.  Even though in the whole cell lysate the PtpA antisera bound several 
proteins, a band of the predicted size of PtpA and the same size as purified PtpA protein 
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was visible in the whole cell lysate.  However, in the culture filtrate we were unable to 
detect any protein of the expected size of PtpA (Figure 4-1). Our inability to detect PtpA 
in the culture filtrate precludes us from drawing any conclusion about the possibility of 
PtpA export being SecA2-dependent.  
 
SapM protein levels are SecA2-dependent.  
  
We also evaluated the secretion of SapM, which is a phosphatase proposed to be 
an effector of phagosome maturation. SapM is shown to cleave the phosphate, 
preferentially off of phosphotydlinositol 3-phosphate (PI(3)P) (22, 27). Because PI(3)P is 
an important signaling molecule on the surface of the phagosome, that is required for 
phagosome maturation, SapM is proposed to influence phagosome maturation by 
reducing PI(3)P levels on the phagosome (27).  
Western blot analysis with SapM antibody recognized a single band of the predicted size 
(30 kD) in both the whole cell lysate and the culture filtrate fractions of M. tuberculosis. 
The level of SapM protein was reproducibly less in the culture filtrates of the ΔsecA2 
mutant compared to H37Rv, and, the level of SapM protein was also reduced in the cell-
associated fraction (WCL) of the ∆secA2 mutant. Importantly, the SapM phenotype was 
complemented in trans by adding back a copy of secA2 on a plasmid (Figure 4-2A). By 
looking at cell fractions on a Western blot, we found that the cell-associated SapM was 
almost entirely in the cytoplasm as opposed to the cell wall or membrane (Data not 
shown). 
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Figure 4-1. Secretion of NdkA and LpdC is independent of SecA2. 
Western blot analysis from whole cell lysates and concentrated culture 
filtrates prepared from the wild type H37Rv and ∆secA2 mutant strains 
of M. tuberculosis. NdkA and LpdC are detected in both wild type and 
∆secA2 mutant culture filtrates at comparable levels. PtpA was not 
detected in culture filtrates. A band that ran at the size of a PtpA 
positive control was present in the whole-cell lysate, but absent in the 
culture-filtrate fraction. WCL lanes were loaded with equal protein, 1-5 
µg protein depending on available material, CF lanes were loaded for 
cellular equivalents between strains. 
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 The reduced cytoplasmic SapM levels where we found lower levels of SapM 
were detected in independent samples prepared from the ∆secA2 mutant grown in 
different culture conditions, including media that was designed to mimic the environment 
of the phagosome (figure 4-2B).  The difference in WCL associated SapM was 
quantitated and found statistically significant by densitometry of Western blots (Figure 4-
2B).  
Using a previously reported phosphatase assay designed to filter out background 
phosphatase activity in order to quantify SapM activity of M. tuberculosis derived 
samples, we assessed SapM activity in culture filtrates (22). To filter out background 
phosphatase activity, the assay uses tartrate in all reaction buffers. Tartrate is an inhibitor 
of some phosphatases, but SapM activity is unaffected by tartrate (22). Using this assay, 
we measured phosphatase activity in culture filtrates of the ∆secA2 mutant compared to 
H37Rv and the complemented strain. We loaded equal total CF protein to each assay as 
determined by BCA assay. We found significantly less phosphatase activity in the 
supernatant of the ΔsecA2 mutant compared to H37Rv and the complemented strain 
(Figure4-2C).  The phosphatase activity we assayed in these reactions was tartrate 
resistant and molybdate sensitive (data not shown), which is characteristic of SapM (27). 
The results from this phosphatase assay are consistent with our western blots.  However, 
it should be noted that the assay used here may not be exclusive for SapM.  The 
phosphatase assay we used could detect any other tartrate resistant molybdate sensitive 
phosphatases that may be present in M. tuberculosis culture filtrates. 
Taken together, our results show an effect of SecA2 on SapM protein levels and a 
reduction in phosphatase activity that is consistent with less secreted SapM. In the 
 107 
presence of a secretion defect one might expect to see the levels in the whole cell lysate 
be unaffected or accumulate. However, because SapM levels were reduced in the whole 
cell lysate as well as in culture filtrates it is not immediately clear if this difference 
reflects a role for SecA2 in SapM secretion.  
 To further characterize the relationship between lower SapM levels and the 
∆secA2 mutation, we tested if sapM transcript levels were also reduced in the ΔsecA2 
mutant of M. tuberculosis.  Using quantitative RT-PCR we measured the transcript levels 
of sapM relative to the rpoB gene, and found levels of sapM transcript to be equal 
between H37Rv and the ∆secA2 mutant (Figure 4-2D). The rpoB gene encodes the Beta 
subunit of RNA polymerase, which works as an internal control for total RNA because it 
should have constant transcript levels between strains. This data rules out the possibility 
that lower levels of SapM protein were the result of altered sapM transcription in the 
∆secA2 mutant.   
 
4.3- Discussion 
 In this chapter, we began the process of determining which effectors of 
phagosome maturation arrest are SecA2-dependent. In these initial experiments we 
obtained antibodies from other investigators to test putative effectors of phagosome 
maturation arrest for evidence of export by the accessory SecA2 system.  
We compared culture filtrates from H37Rv and the ∆secA2 mutant for LpdC and NdkA 
localization. The antibodies we used reacted with a single protein band of the proper size 
on the western blots. In these experiments, the levels of LpdC and NdkA were 
comparable in cultures filtrates of H37Rv and the ∆secA2 mutant. Thus, SecA2 appears 
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to have no role in the export of LpdC or NdkA. We also attempted to monitor PtpA 
secretion by the two strains.  While the antibody did identify PtpA protein in the whole 
cell lysate, we could not detect PtpA in culture filtrates of either H37Rv or the ∆secA2 
mutant.  This negative result of testing for PtpA secretion prevents us from drawing any 
conclusions about the potential for the SecA2 system to be exporting this effector.  Even 
though PtpA is demonstrated to be secreted by M. tuberculosis growing in host cells it is 
likely that the proteins is not highly expressed by in vitro grown M. tuberculosis (2).  In 
order to monitor the secretion of PtpA we will need to test M. tuberculosis strains 
engineered to express the protein from a constitutive promoter.  
When we tested for SapM secretion, we found that that the SecA2 system affects 
the levels of SapM protein in both the culture filtrate and whole cell lysate.  This reduced 
SapM phenotype was reversed when the ∆secA2 mutant was complemented in trans, 
which demonstrates this phenotype is attributable to the lack of SecA2.  Furthermore, 
phosphatase assays designed to monitor SapM activity in culture filtrates were consistent 
with the western blotting results.   
The relationship between SecA2 and SapM remains to be clarified. Quantitative RT-PCR 
data argues against the possibility of SecA2 indirectly affecting transcription of the sapM 
gene. Like the two known SecA2 substrates in M. smegmatis, sapM encodes a N-terminal 
Sec signal peptide. One possibility is that SecA2 is required for SapM export and the 
resulting defect in SapM export that occurs in the ∆secA2 mutant results in degradation of 
the non-exported protein. 
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Figure 4-2. SapM levels are reduced in the ∆secA2 mutant. A. Western blot 
for SapM, shown is a representative of triplicate whole cell lysate samples 
from H37Rv, the ∆secA2 mutant, and complemented strain that were grown in 
7H9 and Sauton media. B. Whole cell lysates from bacteria cultured in low pH 
7H9 with propianate, quantitated by densitometry. Bars represent mean of 
independent triplicate samples +SD, *p≤0.05 by Student’s t test. C. 
Phosphatase assay of concentrated supernatants, data is normalized to 
H37Rv as 100% activity. Strains were grown in 7H9 and Sauton media. Bars 
represent mean of independent triplicate samples +SD. *p≤0.05 by Student’s t 
test. D. Real-time PCR data comparing transcript levels from H37Rv to the 
∆secA2 mutant. Strains were grown in 7H9 media. Bars represent mean of 
triplicate samples +SD. 
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There is precedent for non-exported proteins in the cytoplasm being degraded 
when their cognate export system is absent (8, 10).  Thus, it is possible that the reduced 
level of SapM in the ∆secA2 mutant is due to an export defect resulting in less protein 
secreted into culture media and degradation of the non-exported protein that accumulates 
in the cytoplasm.  Another possibility is that the impact of SecA2 on SapM protein may 
be independent of a role in export and more simply be to stabilize the protein in the 
cytoplasm.  In this case in the ∆secA2 mutant there would be less protein in the 
cytoplasm available for secretion. To determine if SecA2 is involved in the process of 
SapM secretion we plan to employ more sensitive pulse-chase protocols that have 
previously been used to study protein secretion (8). 
While our data shows the ∆secA2 mutant to secrete less SapM, we also do not yet 
know if the reduction in SapM alone can account for the ∆secA2 mutant defect in 
arresting phagosome maturation. While we do see a difference in SapM levels between 
H37Rv and the ∆secA2 mutant, the difference is a modest one. One approach we plan to 
take to address this question is to overexpress SapM in the ∆secA2 mutant and see if this 
rescues the phagosome maturation phenotype observed in the absence of the SecA2 
system. If SapM overexpression can overcome the difference in phagosome maturation 
and intracellular growth between H37Rv and the ∆secA2 mutant, it would argue that the 
defect in SapM secretion is the cause of the ∆secA2 mutant growth defect. However, the 
M. tuberculosis process of blocking phagosome maturation is likely to be complex with 
potentially redundant effectors. Therefore, if SapM overexpression does not rescue the 
∆secA2 mutant growth defect, it could be because multiple effectors of phagosome 
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maturation, including SapM, are exported by the SecA2 system.  In the mean time, 
continuing efforts in our laboratory are underway to identify additional SecA2 dependent 
exported proteins that may be effectors of phagosome maturation.   
 
 
4.4- Materials and Methods 
Bacterial strains and growth conditions 
 
 In this study we used Mycobacterium tuberculosis wild type strain H37Rv, and 
the ∆secA2 mutant (mc23112) generated in the H37Rv background (5). M. tuberculosis 
strains were cultured in liquid Middlebrook 7H9 media supplemented with 0.05% Tween 
80, 0.5% glycerol, 1× albumin dextrose saline (ADS). Sauton media used for preparation 
of culture filtrates contains the following in one liter of media: 4 g DL-asparagine, 2 g 
sodium citrate, 0.5 g K2HPO4, 0.5 g MgSO4-7H2O, 50 mg ferric ammonium citrate, and 
48 ml glycerol. The final media is pH adjusted to 7.4 and filter sterilized through a 0.22 
µm filter. Media used to mimic phagosomal conditions was 7H9 with 
0.1% glycerol, 1mM proprionic acid, 0.1% tyloxapol, 0.1M MES (buffer), 0.5% BSA, 
and is pH adjusted to 6.5. 
 
Culture filtrates and phosphatase assay  
 
For culture filtrate collection, cultures at log-phase growth in 7H9 were washed in 
Sauton media, and added to 50ml Sauton media in roller bottles at an OD600 of 0.2-0.3. 
Cultures were incubated at 37°C for 24 hours. Then the entire 50 ml culture was 
centrifuged at 4000 rpm in a Sorvall Legend RT centrifuge. The supernatants were 
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collected and double filtered with a 0.2µm filter. Culture Filtrate proteins were 
concentrated 100 fold using 15 ml capacity 10,000 MW cut off centrifuge filters 
(Centricon). Samples were centrifuged at 3,000 rpm and sample was added until the 
entire 50 ml was concentrated to < 500 µl. The bacterial pellet from the culture was fixed 
in 10% formalin overnight and later used to prepare whole cell lysates by bead beating in 
protein extraction buffer (3, 14). SapM activity was assayed as described previously (22). 
Protein concentration was assayed using a BCA assay (Pierce) and equal concentration of 
CFP protein (3-5 µg depending on available material) was added to each assay. In a 96 
well plate 10x buffer of 1M Tris base pH 6.8 with 20 mM sodium tartrate to inhibit 
background phasphatase activity was added to each assay and 50mM p-nitrophenyl 
phosphate (pNPP) samples were brought to 200 µl total volume.  In samples with 
molybdate, 1 mM sodium molybdate was added to the sample prior to adding CF protein. 
The plate was incubated at 37°C in a TECAN automated plate reader, and the absorbance 
at 405nm was measured every minute for two hours. Phosphatase activity cleaves pNPP, 
which creates a color change and an increase of OD405 absorbance. Over the linear portion 
of the kinetic assay we calculated the rate of pNPP conversion by calculating the slope of 
the line generated by plotting OD405 in the y-axis and time in the x-axis. These slopes 
were then normalized to the H37Rv rate of change, which we set to 100%.  
 
Western blotting 
 
Equal amounts of protein samples from whole cell lysates (1-5µg depending on 
available material) or concentrated culture filtrates (cell equivalents between strains) 
were run on a 12% SDS-PAGE gel, and then transferred to nitrocellulose membranes. 
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After transfer, the membranes were blotted with primary antibodies. Antibodies to M. 
tuberculosis proteins were kind gifts of Dr. Vojo Deretic, University of New Mexico 
(SapM), Dr. Zakaria Hmama, University of British Columbia (LpdC and NdkA), and Dr. 
Yossef Av-Gay, University of British Columbia (PknG and PtpA). Antibodies were used 
at the following dilutions (SapM 1:2000, LpdC 1:2,000, NdkA 1:2,000, PknG 1:1,000 
and PtpA 1:10,000) Secondary antibodies were either conjugated to horseradish 
peroxidase or alkaline phosphatase. Blots were then developed using a horseradish 
peroxidase or alkaline phosphatase substrate.  Blots were visualized with direct film 
exposure or a phosphoimager. For quantitative westerns, fluorescence was quantified 
using a phosphorimager and ImageQuant 5.2 (Molecular Dynamics). 
 
Quantitative real time PCR 
 
Quantitative real-time PCR (qRT-PCR) was run on RNA samples previously 
prepared for microarray analysis. Bacteria were grown in roller bottles using 7H9 with 
Tween-80 and ADS.  mRNA was prepared by Meghan Feltcher and cleaned up using a 
DNA-Free RNA kit (Zymo). Prior to clean-up RNA extraction was performed as follows: 
Bacterial culture is lysed in chloroform/methanol 3:1 mix. An equal volume of TRIzol 
reagent (Invitrogen) is used to separate protein and lipids from the nucleic acids. After 
thorough mixing of TRIzol and M. tuberculosis lysate, samples were centrifuged and the 
aqueous layer transferred to a fresh tube. Then an equal volume of isopropanol was added 
to the tube to precipitate nucleic acids overnight at -20°C. The nucleic acids were then 
pelleted by centrifugation and the pellet washed with 70% ethanol. After washing the 
nucleic acids were resuspended in H2O and treated with DNAse. Primers were designed 
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to sapM (ATCGTTGCTGGCCTCATGG and AGGGAGCCGACTTGTTACC) and to M. 
tuberculosis rpoB (ACAGAAGCTAGTCCTAGTC and 
ACCGATCAGCCACTCGAAC), which was used as a normalization control as done 
previously (16). Primers were tested on M. tuberculosis DNA to be sure that only one 
product was produced. qRT-PCR reaction was run using a SensiMix Syber and 
Fluorescein One-Step kit (Bioline). mRNA template was loaded at 48 ng/20 µl reaction. 
Reactions were run on an iCycler (BioRad).  
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CHAPTER V 
 
 
 
 
 DISCUSSION 
 
 Mycobacterium tuberculosis infects about one-third of the world’s population and 
causes a substantial amount of mortality worldwide (39). Currently, the vaccine to 
prevent M. tuberculosis infection is questionable at best (11), and drug regiments are 
extended and difficult to administer effectively, especially in developing nations where 
tuberculosis is endemic. Moreover, with the emergence of strains of M. tuberculosis that 
are resistant to first-line and second-line drugs, the need for new treatments and vaccines 
to prevent the spread of this bacterial pathogen is urgent. A better understanding of the 
pathogenesis of M. tuberculosis should help to develop new strategies for targeting 
tuberculosis with drugs, or for eliciting protective immunity with improved vaccines.  
The research presented in this thesis focuses on the role of secreted proteins and 
the SecA2 protein export pathway in M. tuberculosis pathogenesis.  In this research we 
used a ∆secA2 deletion mutant strain of M. tuberculosis to dissect the role of the SecA2 
protein export pathway in our macrophage and mouse infection models.  Going into the 
project we already knew that the SecA2 protein export pathway had a role in virulence 
from data showing that the ∆secA2 mutant is defective for growth in macrophages and 
mice (2, 19). However, we did not know the cause of this intracellular growth defect.  
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Thus, we do not know the role SecA2 plays in virulence. The ∆secA2 mutant does not 
have a growth defect in vitro, ruling out a general slow growth phenotype(2).  
At the start of this research, there were three reported phenotypes for ∆secA2 
mutant infected macrophages that could possibly explain its intracellular growth defect. 
First, macrophages infected with the ∆secA2 mutant produce increased levels of reactive 
nitrogen intermediates (RNI). Second, the ∆secA2 mutant induces higher levels of 
proinflammatory cytokines by infected macrophages(19). Third, the ∆secA2 mutant 
induces more apoptosis than wild type M. tuberculosis in infected macrophages(16).  
 
Increased macrophage production of RNI does not explain the ∆secA2 mutant 
intracellular defect. 
 
Previous data from our laboratory ruled out a failure to resist either RNI or 
reactive oxygen species (ROS) as the sole cause of the ∆secA2 mutant growth defect. 
Specifically, it was shown that the ∆secA2 mutant remains attenuated for growth in 
macrophages that fail to produce RNI (NOS2-/-) or ROS (gp91phox-/- or p47phox-/-)(19).  
While these past results do not completely rule out a role for SecA2 in protecting against 
or limiting reactive radical stresses, these results do indicate the existence of another role 
for SecA2 in promoting intracellular growth. 
 
The increased inflammatory response elicited by the ∆secA2 mutant is not sufficient 
to explain the intracellular growth defect. 
 
 Compared to H37Rv, the M. tuberculosis ΔsecA2 mutant induces an increased 
inflammatory response in infected macrophages as shown by higher levels of TNF-α, IL-
6 and RNI. TNF-α, IL-6 and RNI all play important roles in controlling M. tuberculosis 
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replication in macrophages and mice (5, 12, 13, 20, 22).  Therefore, we hypothesized that 
the increased inflammatory response elicited by the ΔsecA2 mutant may be responsible 
for controlling the intracellular replication of the mutant. In Chapters two and three of 
this thesis we tested this possibility by eliminating components of the inflammatory 
response and asking if this rescued the mutant phenotype. Our results indicate that the 
increased inflammatory response to the ∆secA2 mutant is not sufficient to explain the 
intracellular growth defect. Specifically, we worked with mice and macrophages deficient 
in the production of TNF-α. TNF-α has been shown to be important for activating 
macrophages synergistically with interferon gamma, thus increasing the antimicrobial 
capacity of macrophages and allowing them to contain M. tuberculosis replication (12). 
We also tested whether a broader inflammatory response to M. tuberculosis is important 
for controlling the ΔsecA2 mutant using mice and macrophages lacking the adaptor 
protein MyD88. MyD88 has been shown to be involved through Toll-like receptor (TLR) 
signaling for production of TNF-α, IL-6 and RNI in response to M. tuberculosis (3, 15, 
18, 25, 28, 34, 35, 37). However, when the ∆secA2 mutant was tested in the TNF-α-/- or 
the MyD88-/- mice and macrophages the mutant remained attenuated for growth. Thus, 
while both TNF-α and MyD88 are important for controlling M. tuberculosis infection, 
neither appears to be necessary for the ΔsecA2 mutant growth defect. Our results argue 
that the role of the SecA2 system in promoting intracellular growth in macrophages can 
not simply be to dampen the macrophage inflammatory cytokine response to M. 
tuberculosis.  
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The pro-apoptotic phenotype elicited by the ∆secA2 mutant is unable to explain the 
intracellular growth defect. 
 
 The ∆secA2 mutant also induces higher levels of apoptosis of infected 
macrophages than wild type M. tuberculosis(16). This difference in apoptosis is 
attributed to the defect in SodA secretion reported for the ∆secA2 mutant (16). Because 
apoptosis has been demonstrated to control and even kill multiple mycobacterial species 
including M. tuberculosis (8, 14, 24), we were interested in testing whether increased 
apoptosis exhibited by ∆secA2 mutant infected macrophages was responsible for the 
growth defect of the ∆secA2 mutant. To test the role of apoptosis in the ∆secA2 mutant 
phenotype, we took advantage of a plasmid expressing an extra copy of SodA, termed 
αSodA.  When αSodA is expressed by the ΔsecA2 mutant, the apoptosis phenotype of 
the ΔsecA2 mutant is reversed. We tested the same ∆secA2 mutant strain expressing 
αSodA for growth in macrophages and mice to assess the role of apoptosis in the ∆secA2 
mutant growth defect. As shown in chapter three, even though this construct rescues the 
apoptosis phenotype it does not rescue either the macrophage or the mouse growth defect 
of the ∆secA2 mutant. In fact, expression of αSodA in the ∆secA2 mutant exacerbated 
the virulence defect of the mutant in a mouse. We conclude from these results that the 
pro-apoptotic phenotype of the ∆secA2 mutant is not responsible for the growth defect, 
either in mice or macrophages.   
 Our observation that the ∆secA2 mutant expressing αSodA exhibited a more 
severe attenuated phenotype than the ∆secA2 mutant in mice was unexpected. One 
possibility is that overexpression of SodA succeeds in converting superoxide to peroxide 
but that the catalase KatG, which has been shown to be SecA2 dependent for export, is 
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not able to complete the detoxification and the bacteria is left in a environment that is 
more toxic due to high levels of peroxide. Another possibility is that ROS levels, which 
are important signals for the immune response (10), are deregulated by overexpression of 
SodA. The deregulated levels of ROS could lead to a more robust immune response, 
which could be acting to suppress the growth of the bacteria.  
 The ∆secA2 mutant has also been shown induce a more robust cytotoxic T-cell 
response than H37Rv in murine infection. This adaptive immune response to the ∆secA2 
mutant is thought to be caused by the pro-apoptotic phenotype of the mutant in infected 
macrophages (16). The more robust T-cell response makes the ΔsecA2 mutation an 
attractive addition to a live attenuated M. tuberculosis vaccine strain. In this thesis, we 
tested the possibility that the pro-apoptotic phenotype of the ∆secA2 mutant was 
responsible for the intracellular growth defect. In these experiments we ruled out the pro-
apoptotic phenotype being responsible, at least on its own, for the intracellular growth 
defect of the mutant. However, our data does not preclude the hypothesis that the ∆secA2 
mutant induces a more robust T-cell immune response via increased apoptosis. Our data 
does, however, separate two distinct functions for SecA2: a role in suppressing apoptosis 
and a role promoting intracellular growth.  
Thus, the results of testing the significance of the three reported macrophage 
phenotypes of the ΔsecA2 mutant, (increased RNI, increased inflammatory cytokine 
response, and increased apoptosis) failed to uncover the specific role for SecA2 in 
promoting growth in macrophages and mice.  These results led us to consider other 
possibilities to explain the function of the SecA2 system in promoting intracellular 
growth, such as a role in modifying the normal process of phagosome maturation.    
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The ∆secA2 mutant traffics to a more mature phagosome than does wild type M. 
tuberculosis.  
 
It has long been known that M. tuberculosis prevents phagosome maturation(1), 
and blocking phagosome maturation has been considered an integral part of M. 
tuberculosis virulence. Because exported proteins are implicated in the process of M. 
tuberculosis phagosome maturation arrest, we tested the possibility that the accessory 
SecA2 protein export system is important for blocking phagosome maturation. Our data 
in chapter three shows the ∆secA2 mutant to be defective in the process of phagosome 
maturation arrest. Compared to H37Rv, the ΔsecA2 mutant resides in a phagosome that is 
more acidic and stains positive for surface markers of phagosome maturation V-ATPase, 
CD63, and Rab7. However, while these markers indicate phagosome maturation it should 
be pointed out that they are not unique to the fused phagolysosome. Thus, we do not 
know if the ΔsecA2 mutant ends up in a terminally fused phagolysosome. Other assays, 
such as fluorescent dextran fusion assays or electron microscopy, which we have not 
managed to successfully use in our system, would be required to define phagosome-
lysosome fusion of ΔsecA2 mutant containing phagosomes. 
It has been speculated that any M. tuberculosis mutant that fails to grow or is 
metabolically inactive in a macrophage, will eventually traffic to a more mature 
phagosome(21, 27).  This raised the possibility that the ΔsecA2 mutant is in an acidified 
phagosome as a secondary consequence of a failure to grow in macrophages, as opposed 
to being the cause of the mutant intracellular growth defect.  To test whether all 
intracellular growth defects of M. tuberculosis mutants lead to localization in a mature 
phagosome, we examined phagosome acidification of five other mutants with 
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intracellular growth defects, including the leucine auxotroph ∆leuD mutant (17, 23). 
Despite having intracellular growth defects, four out of the five mutants tested behaved 
like wild type in maintaining the ability to block phagosome maturation at 24 hours post 
infection. In fact, the ∆leuD mutant still blocked phagosome acidification out to 72 hours 
post infection. The fifth mutant tested, an esx-1 mutant, was chosen as a positive control 
for a mutant known to have a defect in blocking phagosome maturation(4, 21, 40), and 
our results agreed with previous findings that the esx-1 mutant resides in a more acidic 
phagosome with surface markers of phagosome maturation in comparison to H37Rv.  
Our finding that four individual M. tuberculosis mutant strains with defects in 
intracellular growth maintained a phagosome maturation block argues against the 
possibility that any intracellular growth defect results in phagosome maturation. This left 
us with the other possibility that the phagosome maturation that occurs with the ∆secA2 
mutant is due to a specific defect in exporting an effector protein involved in the process 
and that the failure to block phagosome maturation is the cause of the intracellular growth 
phenotype. 
 
Increased phagosome maturation leads to the ∆secA2 mutant growth arrest.  
 
While blocking phagosome maturation has long been considered integral to M. 
tuberculosis intracellular survival and growth(30), surprisingly few experiments have 
directly tested whether phagosome acidification and maturation directly affect M. 
tuberculosis intracellular replication. From previous research performed in numerous 
laboratories, a strong correlation exists between mutants that fail to block phagosome 
maturation and mutants that have intracellular growth defects (4, 21, 26, 36). However, 
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the causal nature of the relationship between failure to block phagosome maturation and 
intracellular growth inhibition had not been defined. In addition, there are a few reports 
of M. tuberculosis mutants that fail to block phagosome maturation but grow normally in 
macrophages. These exceptions raise the question about the need to block phagosome 
maturation to allow intracellular growth. 
The ∆secA2 mutant provided us with the opportunity to test if failure to block 
phagosome maturation could, in fact, be growth inhibitory.  To answer the question of 
whether phagosome maturation controls the ∆secA2 mutant’s intracellular replication, we 
utilized chemical inhibitors of phagosome maturation. Specifically, bafilomycin A1 and 
concanamycin A are inhibitors of the vacuolar ATPase (V-ATPase) the protein pump that 
is responsible for acidifying the phagosome(9). Treatment of infected macrophages with 
these inhibitors rescued the ∆secA2 mutant from an acidified phagosome, and rescued the 
∆secA2 mutant growth defect. The inhibitors also had a mild positive effect on 
intracellular replication of H37Rv, which makes sense because a fraction of wild type M. 
tuberculosis is found in acidified phagosomes. Importantly, treatment with the inhibitors 
did not rescue intracellular growth defect of the ∆leuD mutant, which remains in a neutral 
phagosome, indicating the effect of these inhibitors was specific for the ∆secA2 mutant.   
In addition to showing the ∆secA2 mutant growth phenotype in macrophages is 
attributable to its defect in blocking phagosome maturation, these experiments make a 
larger statement about the importance of M. tuberculosis avoiding phagosome 
maturation.  Our experiments demonstrated a causal relationship between phagosome 
maturation and M. tuberculosis growth arrest.  
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SecA2 dependent effectors of phagosome maturation 
 
The ΔsecA2 mutant fails to block phagosome maturation compared to H37Rv. 
Because the failure to block phagosome maturation appears to be specific to the lack of 
the SecA2 export pathway, we hypothesize that one or more effectors of phagosome 
maturation depend on SecA2 for export. As a starting point to identify such effectors, we 
looked for SecA2 dependent export of a set of putative protein effectors of phagosome 
maturation. As reported in chapter four, one of the proteins tested, the secreted 
phosphatase SapM, was present at reduced levels in the ∆secA2 mutant.  Less SapM was 
detected in culture filtrates prepared from the ∆secA2 mutant. In addition, we found less 
cell associated SapM, indicating that decreased SapM levels may be a result of decreased 
cytoplasmic stability. One possibility is that cytoplasmic stability is reduced in the 
∆secA2 mutant independent of an export defect. The other possibility, for which there is 
precedent, is that cytoplasmic stability is compromised as a result of an export defect (6, 
7). More research will be required to elucidate the role of SecA2 in SapM export. 
SapM is shown to cleave phosphates from phosphatydlinositol-3-phosphate, an 
important signaling molecule required for phagosome-lysosome fusion(38). Thus, SapM 
is potentially a SecA2 dependent effector of phagosome maturation. However, 
phosphatase levels were only mildly reduced in the ∆secA2 mutant secreted fraction. 
Additionally, the published study linking SapM and phagosome maturation arrest did not 
go as far as showing a direct role of SapM in phagosome maturation arrest(38). For 
example, it has yet to be shown that a sapM mutant is defective for blocking phagosome 
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maturation. The current data only shows that SapM preferably dephosphorylates PI(3)P, 
it does not directly show that this activity leads to phagosome maturation arrest (38).  
Further studies of the SecA2 exported proteome and dissection of the role of 
SapM in phagosome maturation are required to better understand the role of SecA2 in 
phagosome maturation arrest. The current list of putative effectors of phagosome 
maturation is long and there are probably effectors with redundant functions. Thus, there 
may be more than one effector exported by the SecA2 system. To identify other SecA2 
dependent exported proteins it may be necessary to use large-scale proteomic methods. 
Previous studies have employed 2D gel electrophoresis methods to discover SecA2 
dependent exported proteins, and the limitations of these studies have been reached. More 
sensitive quantitative mass spectrometry is an alternative approach that should be 
considered for discovering new SecA2 dependent exported proteins.  
As an alternative approach, for identifying SecA2 dependent effectors of 
phagosome maturation, we have also considered a genetic screen based on TraSH 
analysis (29, 31-33). TraSH is a transposon based genetic method used to determine 
genes that are required for pathogen survival in a particular environment. Using TraSH, 
we would compare the genes required to replicate in a macrophage to the genes required 
to replicate in a macrophage treated with bafilomycin A1. Because the ΔsecA2 mutant is 
specifically rescued in macrophages by addition of bafilomycin A1 or concanamycin A, 
TraSH analysis could be used to find similarly rescuable mutants in macrophages. 
Mutants that can be rescued like the ΔsecA2 mutant with bafilomycin A1, would be 
considered candidate SecA2 dependent effectors of phagosome maturation. 
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Conclusion 
 
The SecA2 system has an impact on multiple components of the innate immune 
response, such as cytokines, apoptosis, and here we show phagosome maturation. We 
have shown in this thesis that the SecA2 protein export pathway is required for blocking 
phagosome maturation. Furthermore, blocking phagosome maturation is required for M. 
tuberculosis intracellular replication (Figure 5-1). While a role in exporting the SapM 
phosphatase may prove to be the important contribution of the SecA2 system to 
phagosome maturation arrest, we have yet to prove this to be the case. It is certainly 
possible that there are additional effectors of phagosome maturation arrest that are 
controlled by the SecA2 system. This work shows a direct causal link between 
phagosome maturation and M. tuberculosis growth arrest reasserting phagosome 
maturation arrest as a critical step in virulence. Further, we have opened up a new avenue 
for discovering effectors of phagosome maturation by finding SecA2 exported proteins.  
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Figure 5-1. The accessory SecA2 protein export system promotes 
growth in macrophages by blocking phagosome maturation. In this 
model SecA2 is required for export of one or more effectors of phagosome 
maturation SapM as one potential effector and the question mark indicates 
other possible effectors. Without secA2 the effectors are not properly 
localized to prevent phagosome maturation and the mutant containing 
phagosome progresses to a late-endosome or possibly a phagolysosome, 
and bacterial replication is arrested. It is unclear whether or not the ∆secA2 
mutant blocks phagosome-lysosome fusion. 
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